Tropical diseases :Psychiatric 
disorders,Infections : 
toxoplasmosis , rubella , RTI, 
STI, vaginal infections
Psychiatric disorders 
INTRODUCTION
Meaning 
Any disturbance of emtional equlibrium , as 
manifested in maladptive behaviour and impaired 
functioning caused by genetic , physical, 
chemical,biological, psychological or social or 
cultural factors . Also called as emotinal illness, 
mental illness , or mental disorders . Disorder can 
occur any where during the period of pregnancy 
Mosby medical dictionary
Common psychiatric challenges in pregnant 
women 
1. MATERNAL STRESS 
Animal research shows that stress produce both long 
term and short term effects on the foetus 
Human studies showed – 6 month dutch famine of 
1944- 1945 , showed the pregnancy outcome for 
women who experienced severe food shortage 
 Data showed , affected pregnancy had shorter 
gestation and higher risks for still births , with 
impact more pronounced if exposed in the first 
trimester
Babies exposed in third tirmester had large drop in 
birth weights 
Chance for neonatal deaths if exposed in the first 
and third trimesters 
Other research studies show- increased riskfor 
preterm death
2. Mood disorders 
DEFINTION 
Defined as the disorders that have as their dominant 
features a disturbance in the prevailing emotional 
state 
Incidences 
In review of 21 research studies , prevalence of 
depression during pregnancy as 7.4% during first 
trimester , 12.8%during second trimester , 
12%during third trimester
CRITERIA FOR DIAGNOSIS 
For diagnosis major depression should have the 
following signs and symptoms 
1. depressed mood , often with spontaneous crying 
Markedly diminished interest in activities 
Insomnia or hypersomnia 
Weight changes ( increased or decreased ) 
Pschomotor retardation or agitation 
Fatigue 
Feeling of worthlessness or inappropriate guilt 
Suicidal ideation 
Dimished ability to concentrate 
APA 2000
TREATMENT 
Avoid giving antidepressants during the first 
trimester 
Symptoms are severe ( mood lability , 
disorganization, inability to care for self , cognitive 
deficit ), then medication is considered 
Fluoxetine ( prozac in small doses) 
Other options include , tricyclic and tetracyclic 
antidepressants , but excessive doses known to 
maternal toxicity like urinary retention , irritability , 
with fetal complications
3. ANXIETY DISORDERS 
Most common mental disorder 
Includes phobias ( irrational fears , that leads to 
avoid objects, persons or situation ) panic disorders , 
generalized anxiety disorders (constant worry , 
untreated to any event ), obsessive compulsive 
disorders and post traumatic stress disorder
TYPES 
A. PANIC DISORDER 
Definition 
Repeated unprovoked episodes of intense fear which 
develop without warning and are not related to any 
specific event 
Incidences 
In a estimated systemic review showed an 1-2% in 
pregnancy, with women having no change or 
improvement of symptoms
Study of 38,000 mothers in hungarian , reported 
0.5% of mothers carried a diagnostic panic disorders 
and high rate of preterm labour
3. Obsessive Compulsive Disorders (OCD) 
Meaning 
Includes reccurrent , persistent and intrusive thoughts 
that cause anxiety , which a person tries to control by 
performing repetitive behaviours or compulsions 
(APA 2000) 
PREVALANCE 
0.2- 1.2% ocds in pregnancy
TREATMENT 
Includes antidepressants medications ( SSRI), 
Cognitive behavioural therapy and education on 
management of symptoms
POST TRAUMATIC STRESS DISORDER 
PTSD can occur because of any trauma manily 
traumas eg : rape
SYMPTOMS 
RExperiencing the traumatic event 
Persistent avoidance of stimuli 
Numbing 
Difficulty sleeping 
Hyper vigilance 
Exaggerated startle response
Pregnancy because of rape- women becomes 
extremely ambivalent about baby 
Women might avoid examination like pv, if prenatal 
examination triggers memories of original trauma 
( triggered by bodily touch) 
Pregnant women with PTSD have associated 
psychiatric problems such as substance abuse , panic 
disorders , eating disorders and depressions which 
play a vital role in determining fetal outcome
D. GENERALIZED ANXIETY DISORDERS 
INCIDENCES 
8.5% of pregnant women develop generalized 
anxiety disorder
Level of anxieties 
MILD 
Experience and manage tension related to activities 
of daily living 
She sees, hears and is aware of environmental 
stimuli 
Anxiety acts as motivator , helping women establish 
tasks
MODERATE 
Attention focus on immediately concerns , what she 
hears , sees and perceives is compromised 
SEVERE 
Clients perceptual field is restricted significantly, 
narrowing her awareness 
Intent to relieve or reduce anxiety to a more reasonable 
or comfortable level
PANIC 
Experience awe, dread , and terror 
Unable to follow commands 
Increased motor activity 
Loses capacity to think and reason, can dangers self 
or others
OTHER PSYCHIATRIC DISORDERS 
4a. SCHIZOPHRENIA 
 a debilitating psychiatric disorders affecting 1% of 
population 
Etiology 
No theory explains accurately
Clinical manifestations 
Five subtypes of schizophrenia 
1. paranoid – per occupation with one or more 
delusion, frequent hallucination usually auditory, 
organized speech and behaviour with appropriate 
effects 
2.DISORGANIZED – Disorganized speech, 
disorganized behaviour , flat and appropriate affect 
3. CATATONIC- at least two of the following 1. 
motor immobility with waxy flexilibility, or stupor 2. 
puporseless but excessive motor activity not 
influenced but external stimuli and demand
3.Negativism 
4. Maintenance 
5. Mutisms 
4. UNDIFFERENTAITED – delusions , hallucination 
and disorganized speech , but no symptoms that 
meet the predetermined criteria for paranoid 
disorganized or catatonic 
5. RESIDUAL – no prominent delusions, 
hallucinations , disorganized speech , or disorganized 
or catatonic behaviour, negative thoughts , contents , 
form usual perceptual experience
MOOD CHANGES 
Signs and Symptoms 
Experience anxiety , depression, tension, irritation 
Isolates oneself from events and people 
Anhedonia 
COGNITIVE CHANGES 
Disordered thoughts 
Loses capacity to concentrate 
Conversation shifts from one topic to another 
irrerelvant 
Disturbance in thought content – mainly through 
delusion or false beliefs 
Delusions
PERCEPTUAL CHANGES 
Hallucination 
Kinesthetic hallucination 
Illusions 
PHYSICAL CHANGES 
Early stages , clients present with sweaty palms, 
dilated pupils and mild tachycardia , psychomotor 
activity ( restlenesses)
INTERPERSONAL DISTURBANCES 
Inappropriate behaviours 
Bizzare behaviours 
Eg. Bangs her head , interrupt conversation, mutilate 
body part with knifes , attempted suicide, introduce 
inappropriate topic , laugh about that provoke 
saddness
DISTURBANCES IN MOTOR FUNCTIONS 
No interactions with others 
With catatonic , the client becomes rigid and 
unresponsive to crisis
Management 
Primary assessment- interviewing and direct 
observation 
Interviewing focusing on signs and symptoms , 
degree of impaired thoughts processes , risks for 
injury or violence towards self or others , availability 
of support 
Early stage of treatment- focus on improving the 
clients sense of reality ( focus on real events during 
hallucination and delusions ), nurse not to engage in 
arguments , but rather gently introduce doubt , 
attempt to shift clients focus
Nurse should try to listen and try to clarify each 
meaning 
To watch for aggressive behaviours , risky behaviours 
like social isolation 
Nurse to model behaviour which help patient to built 
social skills and learn ways to built rapport with others 
Nurse to assess their knowledge , to provide teaching 
about illness, its symptoms management , necessity of 
following therpeutic regimen , signs of relapse and life 
style accomdation
JOURNAL REVIEW ON PSYCHOTIC DISORDERS 
Psychotic disorders and its affect on fetal outcome 
with schizophrenia reported fewer total life time 
pregnancies , a low rate of live births and a high rate 
of losing the pregnancy 
 Pts with schizophrenia and schizoaffective disorder 
have higher number of chronic disease eg. HTN, DM 
Meta analysis – found a doubling of risk of stillbirth 
in pregnancy with psychotic disorder
Schizophrenia associated with more placental 
abnormalities and cardiac defects 
Another study shows- one third of women with 
active psychiatric symptoms have no contact with 
their psychiatric providers during pregnancy 
Pts with schizophrenia – said to have worse health 
behaviours like lack of exercise , smoking, poor diet 
and substance abuse
Personality Disorders 
 Definition 
Personality disorders are a group of mental disturba 
nces defined byDiagnostic andStatistical Manual of 
Mental Disorders (DSM-IV) 
as "enduring patterns] of inner experience and b 
ehavior" that are sufficiently rigid and deep-seated 
to bring a person into repeated conflicts with 
his or her social and occupational environment. 
Incidences 
SWEDISH STUDY- of 625 primiparous mother , 
found a prevalence of personality disorders to be 
6.4%during pregnancy
DSM-IV classifies personality disorders into three 
clusters based on symptom similarities: 
Cluster A (paranoid, schizoid, schizotypal): Patients 
appear odd or eccentric to others. 
Cluster B (antisocial, borderline, histrionic, 
narcissistic): Patients appear overly emotional, 
unstable, or self-dramatizing to others. 
Cluster C (avoidant, dependent, obsessive-compulsive): 
Patients appear tense and anxiety-ridden 
to others.
DSM-IV classifies personality disorders into three 
clusters based on symptom similarities: 
Cluster A (paranoid, schizoid, schizotypal): Patients 
appear odd or eccentric to others. 
Cluster B (antisocial, borderline, histrionic, 
narcissistic): Patients appear overly emotional, 
unstable, or self-dramatizing to others. 
Cluster C (avoidant, dependent, obsessive-compulsive): 
Patients appear tense and anxiety-ridden 
to others.
4b. EATING DISORDER 
INCIDENCE 
Study with nearly 15,000 women in the uk assessed 
women in their first trimester for active eating 
disorder – found 1.4% women with anorexia 
nervosa , 1.6% with bulima and 0.7% with both and 
a total prevalence of 3.7%
Etiology 
Several theories 
Bielieve it arise , because of complex interactions 
among biological , environmental and socio- cultural 
factors . 
Family functioning, lifestyle and stress
1. ANOREXIA NERVOSA 
Characterized by disturbed body image , extreme 
fear about being fat and emaciations. 
CLINICAL FEATURES 
Primary indicator- refusal to eat , weight below 85% 
normal for their age and height 
Women view their extreme thin bodies as fat 
Dieting , defective obsession with cooking for others 
and extreme exercises
Women with anorexia – tend to be compliant , 
obedient , perfectionists , achieving in school, 
sports , employment 
Physiological consequences of self starvation can be 
life threating to mother and cause PTD of fetus 
Can lead to hypotension, bradycardia , hypothermia , 
chronic constipation and electrolyte imbalance
2. BULLIMA NERVOSA 
Characterized by consumption of extreme amount of 
food (bingeging) with subsequent behaviours to 
eliminate the excess calories (purging) 
Women consume incredible calories in short period 
(2000 to 3000) per episode called as bingeing 
To prevent weight gain , induce vomiting , use 
laxatives , exercise obsessively 
Women will be high achievers 
Physiological complications include changes HR, 
RHYTHM, GASTRIC DILATION , ELECTROLYTE 
IMBALANCE
JOURNAL REVEIWING 
Women with active bulimia compared with women 
with prior diagnosis of bulimia ( with no active 
symptoms) showed twice rates of miscarriage , three 
times like hood of PTD AND nearly 6 times the odds 
gestational diabetes 
Higher rate of hyper emesis gravidarum seen in 
active bulima group 
Women with anorexia , also have significant higher 
risks of gestational diabetes and low birth weight 
ifants
COLLABORARIVE MANAGEMENT 
 treatment is hard because clients deny their 
problems 
Combination of therapy , cognitive behavioural 
therapy , family therapy 
 medication generally not primary treatment 
measure , but can also be treated with anti 
depressants , anti anxiety drugs . Lithium and anti 
convulsants 
Through physical examination, , weight , h/o of 
previous high and low weight , chronology of recent 
weight flucations
h/o of desirable food and fluid intake , any problems 
related to elimination , questions on type of food , 
exercise , difficulty sleeping and energy levels 
Laboratory and cardiac testing , electrolyte 
imbalances 
Main intervention focus on nutritional balance 
Fetal health concerns to be addressed 
Encourage realistic thinking process 
Improving clients self esteem, bodyimage and 
develop effective coping and problem solving 
strategies 
Extreme cases hospitalization is required
INTIMATE PARTNER VIOLENCE 
Women who experinece IPV are at risk for 
developing depression, anxiety , eating didorder , 
alcoholisms, post traumatic stress disorder and 
numerous other maladise 
( coker , 2005)
Substance abuse in pregnancy 
Defintion 
Refers to the continued use of substance despite 
related problems in physical , social or interpersonal 
areas 
( APA/ 2000) 
MAJOR depression and anxiety disorders are the 
psychiatric disorders that commonly occur with 
substance abuse
Risk factors 
Women begin using during period of depression to 
relax , feel more comfortable, to lose weight, to 
decrease stress , or to help slepp at nightn 
Peer pressure in teens 
Lower educational attainment 
Lower rates of employement 
Psychological factors like : low self esteem, tendency 
to seek pleasure , and to avoid pain 
h./o family dysfuntion , psychiatric illness , or 
physical or sexual abuse
BARRIERS TO TREATMENT 
Less than 10% take treatment 
Social stigma, labelling and gulit are social barriers 
Dont seek help, due to fear of losing custody
CONCERNS RELATED TO PREGNANCY 
Use of substance lead to premature labour, abruptio 
placenta , still birth and numerous other 
complications 
Alcohol related , lead to fetal alcohol syndrome 
,symptoms being microcephaly , mental retardation, 
attention deficit , hyperactivity disorder 
Use of cocaine –( fetus) IUGR , organ malformation, 
preterm labour, abruptio placenta , withdrawal 
symptoms to neonate for months
Heroine – withdrawal symptoms for mother and 
infants or both , irritability , poor feeding , 
respiratory complication , and neurological 
difficulties
COLLABORATIVE MANAGEMENT 
Client deny their addictions or blame people or 
circumstance 
Client taught on coping with stressors, repair 
realtionship 
Abstinences , counselling and peer support
PSYCHOPHARMACOLOGIC THERAPY 
DURING PREGNANCY 
Use of psychiatric drugs pose a threat to manage 
psychiatric problems – due to detrimental effects on 
fetus or newborn development 
Assumed that all psychotropic drugs cross the blood 
placental barrier
1. DETREMINING RISK AND BENFITS 
Health care providers to assess the risks and 
benefits of maternal drug therapy 
Concerns include – possibility of Lbw babies , 
sucidality, inability to engage in appropriate 
obstetric care 
Basic rule to avoid administering any medication 
Consent made jointly by partner , the women and 
health care worker 
Aims – at maintaining the lowest level of 
therapeutic dose
US FOOD AND DRUG ADMINISTRATION 
Not approved psychotropic agents for treatment of 
mental illness during pregnancy or lactation 
Developed classification system for prescribing 
drugs 
CATEGORY 
1. A - controlled studies shows no risk . Well controlled 
studies have failed to demonstrate risk to fetus 
2.B- no evidence of risk in humans : EITHER animal 
findings show risk , but humans donot or adequate 
human studies have been done
C- risk cannot be ruled out. Human studies are 
lacking and animal studies are either positive for 
fetal risks or lacking as well . Potential benfits amy 
justify potential risks 
D- postive evidence of risk . Investigation shows risk 
to fetus . Potential benefits may outweigh risks 
X- contraindicated in pregnancy . Studied in animal 
and humans shows fetal risks , that clearly outweigh 
any possible benefits to the patient
System and current research – developed creation of 
three categories of somatic risks to fetus and 
nweborns with use of psychotropic agents 
1. teratogenicity and organ malformation 
2. Neonatal toxicity 
3. neurobehavioural and developmental teratogenic 
effects
Medication for psychiatric disorders 
A. ANTIDEPRESSANTS 
A. Tricyclic anti depressants ( TCA’S ) 
API committee on drugs ( 2001) has suggested , 
clinician proceed with caution with use of such drugs 
as support has not been established 
Nullman and colleages ( 1997)- Reported that in 
utero exposure to fluoxetine or TCA’S didnot affect 
either neurodevelopemental or behaviour in 
preschool childrens. 
Other studies showed higher rates of perinatal 
complications
TCA’S cause central nervous system and peripheral 
nervous system side effects , overdose cause death 
Side effects for mother – inlcude weight gain, 
tremors , grand mal seizures , night mares , agitation 
or mania and extra pyradimal side effects , anti 
cholinergic effects
MONOAMINE OXIDASE INHIBITORS ( MAOI’S ) 
Fall in the category” C” of FDA’S 
MAOI’S not to be used during pregnancy 
USEof MAOI’S require dietary restriction associated 
with preventing hypertensive crisis 
Dangerous food include –beer, red wine, aged cheese 
, smoked fish , brewers yeast , beef and chicken livers 
, yoghurts, bananas, soy sauce , chocolates
SELECTIVE SEROTININ REUPTAKE INHIBITORS 
Emerging as first line agent in treatment 
Relatively safe and carry fewer side effects than 
TCA’S 
Not to be taken with DEXTROMETHORPHAN 
(cough syrup ) combination trigger serotonin 
syndrome 
Frequent side effects in mother – gastro intestinal 
disturbances , headache and insomnia 
1/3 rd clients show reduced libido , arousal o 
orgasmic functions
MOOD STABILIZERS 
Used to treat mental illness- mainly bipolar disorder 
Lithium carbonate is major mood stabilizers , but its 
use is contraindicated in pregnancy 
Alternative to lithium in pregnancy are 
anticonvulsants ex. Carbmazepine , valproic acid , 
donazepam
ANXIOLYTICS 
Benzodiazepines are most frequently preferred 
This class drugs can aclumate in the fetus if given to 
the mother for a longer period of time 
These drugs should be withdrawal abruptly amd 
must be tapered significantly before birth to prevent 
infant withdrawal 
Benzodiazepines produce infant withdrawal 
syndrome that last longer than 3 months
ANTIPSYCHOTICS 
Used to manage schizophrenia and other though 
disorders in women 
Msot fall in the “c” category of FDA category , 
indicating they are associated with rare anomalies , 
such as fetal jaundice and anticholingenric effect at 
birth 
Said that all psychotics drugs cross the placental 
barrier, predisposing infants to numerous problems
 studies have shown so far that 3 antipsychotic i.e 
haloperidol, perphenazine , and chloropromazine , 
have shown no direct link to congenital 
malformation 
Other drugs cause in women- extrapyramidal side 
effects , neuroleptic malignant syndrome
Nursing management 
Nurse to see that , the clients have adequate 
knowledge about their health status 
A. DISCUSSING INFORMED CONSENT 
Nursing responsibility to make client is whole 
knowledge about the risk of psychotropic mediation 
during pregnancy . 
Through discussion on risk verus benefits need to be 
done
B.DOCUMENTING RISK VERSUS BENFITS 
Document potential risk for any illness if untreated 
,including risks to the women and fetus and infants 
Critical decison based on scientific knowledge , the 
clients clinical history , cultural consideration and 
personal preferences
C. Promoting community and psychosocial 
interventions 
To Maintain these women in the community 
Community focused interventions- case 
management, rehabilitation , self help groups and 
day hospitalization
D. TEACHING STRESS MANAGEMENT 
Being pregnant , can produce stress 
Body reaction to stress is flight and fight techniques 
Common physical reaction to stress – increased bp, 
palpation, tense muscle , poor or excessive appetite 
and disturbed sleep 
Common symptoms – short tempered , feeling tired 
frequently, eating toomuch or too little , sleeping too 
much or too little , changes in menstrual cycle , 
forgetfullness, frustration, irritability , diffculty to 
concentrate and sleep distubances
Diseases can also occur- heart diseases, DM, irritable 
bowel syndrome , depression ,UTI, asthma 
Management- behavioural change 
Specific strategies – prioritizing responsibilities , 
taking time to relax , exercising , become involved in 
social support systems , healthy perspectives , 
powerful strategies to improve quality of life 
Regular sleep routines
E.ASSISTING WITH ACESS TO HEALTH 
CARE 
F.PROMOTING HEALTH LITERACY
INFECTIONS : 
TOXOPLASMOSIS, RUBELLA , 
RTI’S , STD’S ,VAGINAL 
INFECTIONS
DEFINTIONS 
SEXUALLY TRANSMITTED DISEASES 
A group of communicable diseases that are 
transmitted predominantly by sexual contact and 
caused by a wide range of bacterial , viral , protozoal , 
fungal and ectoparasitites 
REPRODUCTIVE TRACT INFECTIONS 
Infections that occur in the reproductive tract and it 
encompasses both sexually transmitted and other 
common genital tract infections
PREVALANCE 
True incidence of STD’S unknown – because of 
inadequate reporting and secrecy that surround 
them 
1. gonorrhea – 6.2 million 
2. genital chylamyidial infections – 89 million 
3. syphyillis – 12 million 
4. chancroid – 2 million
Viral STD’S 
genital herpes – 20 million 
human papilloma virus infection- 30 million 
trichomoniasis – 170 million 
( who health situvation 1994)
Prevalance of disease in india 
SYPHILLIS – a prevalence of 2.4 
GONORRHEA – most cases are unreported 
80% INFECTED women are asymptomatic 
carriers 
CHLAMYDIA – mostly prevalent in the 
southern states 
DONOVANOSIS- Greater prevalence in the 
coastal region , endemic in T.N, A.P, ORISSA
Epidemi0logy 
A. HOST FACTORS 
AGE – 20- 24 years old,followed by 25- 29 yrs and 
15- 19 yrs 
SEX- morbidity is higher for men then for women, 
but morbidity caused by infection is generally much 
more severe in women 
MARITAL STATUS – the frequency of STD’S is 
higher among single , divorced and separated 
womens than among married couples 
SOCIO ECONOMIC STATUS – individual from low 
socio economic have higher morbidity
B. SOCIAL FACTORS 
PROSTITUTION- prostitutes act as reservoir of 
infections 
major incidences in asia is accounted to prostitution 
BROKEN HOMES – promiscuous women are drawn 
from broken homes eg. Homes that are broken due to 
death of parents , or their separations , reared in 
unhappy homes 
SEXUAL DISHARMONY – married people with 
strained relations, divorced and separated persons are 
often victims of STD’S
EASY MONEY – prostitution provides way for 
occupation and for earning easy money , fostered 
with lack of female employement 
EMOTIONAL IMMATURITY 
URBANIZATION AND INDUSTRIALIZATION- type 
of life styles contribute to infections 
SOCIAL DISRUPTION- caused by disasters , wars , 
civil unrest 
INTERNATIONAL TRAVEL – travellers can import 
and export infections
CHANGING BEHAVIOURS PATTERNS – Moral 
and cultural value , tendency to break from 
traditional ways of life to newer ways of living 
SOCIAL STIGMA – Leads to non detecting of cases , 
not disclosing the case nor the source and hence it 
leads to infection 
ALCOHOLISM- effect boast prostitution
CLASSIFICATION OF SEXUALLY 
TRANSMITTED DISEASES 
A. BACTERIAL INFECTIONS 
1. gonnorrhea- Neisseria Gonorrhea 
2 chlamydia 
3. syphilis -Treponema pallidium 
4. chancroid -Hemophilus ducreyi 
5. Lymphogranuloma venerum- Donavanis 
granulomatis 
6. genital mycoplasmas- Mycoplasma vaginalis 
7. group B streptococcus
B.VIRAL INFECTIONS 
AIDS - HIV 
GENITAL HERPES – Herpes simplex virus (HSV) 
CONDYLOMA ACCUMINATA- HPV 
MOLLUSCUM CONTAGIOSUM- HPV -16,18,31 
VIRAL HEPATITIS – Pox virus 
C. PROTOZOAL 
TRICHOMONAS VAGINITIS- trichomonas vaginalis
d. Fungal 
Monilia vaginitis - candida albicans 
e. Parasites 
Scabies – sarcoptes scabies 
Pediculosis pubis
Effects of sexually transmitted diseases 
1. EFFECT IN THE REPRODUCTIVE TRACT 
Females- Infections , development of ectopic 
pregnancy, infertilty , pelvi inflammatory diseases, , 
chronic pelvic pain 
Males- inflammation of the epididymus , infertility, 
urethral stricutre 
Infants- eye infection, blindness
2.ULCERATION OF URO GENTIAL TRACT, mouth, 
rectum , cardiovascular complications , peripheral 
nervous inflammatory disease , 
3. TRICHOMONIASIS- parasitic infection causing 
vaginitis , arthritis, adverse effect of pregnancy – low 
birth weight babies , premature rupture of 
membrane
4. Inflammation of the lymph node , ulcerative 
genitalia and elephantiasis – effects of chancroid 
and lymphogranulona 
5. Genital herpes –Papular lesions and ulceration 
Carcinomas- hepatocellular carcinomas , caused by 
hepatitis B, kaposis sarcoma , bcell lymphomas
Types of infections 
A. Protozoal infection 
TRICHOMONAS VAGINALIS(VAGINAL 
INFECTION) 
A unicellular protozoan flagellate 
Transmitted through sexual intercourse 
Women usually infects vagina and skene’s duct in men 
Can be present in the lower
SYMPT OMS 
Vaginal discharge – yellow green , frothy or bubbly 
and copious with a strong foul odour 
Cervix and upper vagina often tiny petechiae , due to 
inflammation 
With severe inflammation-vaginal wall, cervix and 
vulva may be oedematous and erythematous 
Moderate to severe itching 
Women- dysuria and dyspareunia secondary to 
inflammation
Contd symptoms 
Symptoms vary form mild to severe 
MILD SYMPTOMS can be- discharge that is thin, 
slight , whitish yellow , without typical foul odour 
Often cervix and vagina demonstrate “ strawberry 
spot”
DIAGNOSIS 
DURING PELVIC EXAMINATION- 
Discharge samples placed on a saline mount and 
examined microscopically 
Motile trichomonades are seen 
Under high power seen as 2 to 3 times the size of 
WBC and their flagella may be seen moving 
Lactobacilli are usually absent, many WBC are 
present, array of vaginal intermediate and parabasal 
epithelial cells are present 
Routine pap smear indicates presence of 
trichomonades
TREATMENT 
Treated with metronidazole (flagyl) 2 gm orally in a 
single dose or 250mg tid for 5 to 7 
days( contraindicate during the first trimester of 
pregnancy ) 
Womens sexual partner also to be treated with 2 gm 
single dose 
When taking to avoid alcohol , because it produces 
abdominal cramps , nausea, vomiting , headache and 
flushing
Lactating women to be treated with 2 grams 
metronidazole , but not to breast feed for 24 hours 
after the therapy 
Metronidazole is contraindicated during pregnancy , 
especially during the first trimester . Clotrimazole 
vaginal cream or tablets at bedtime for 7days can 
provide symptomatic relief
Local vulvar inflammation and dysuria - to be 
treated with Sitz bath or steriod creams 
 For Dyspareunia – avoided for 2 to 3 days to allow 
for healing
Fungal infections 
CANDIDA VAGINITIS ( vaginal infection)/ VULVO 
VAGINAL or yeast infection 
Caused by fungus Candida albicans widely 
distributed in nature , found in skin and mucous 
membrane 
Causes : occurs frequently in women with DM , 
Women taking systematic antibiotics are more 
susceptible to candidas due to suppression of normal 
vaginal flora and changes in PH and enzymes 
Stress – decreases resistances to candida vaginitis 
and hygiene practices such as douching , using 
perfumed oils
SYMPTOMS 
Common symptom is – vulvar and possible vaginal 
pruritis 
Itching may be mild or intense , interfere with rest 
and activities , occur during or after intercourse 
Women c/o of period of dryness 
Others- have painful urination , usually results 
because of excoriation , resulting from scratching
Discharge is thick, white , lampy and cottage cheese 
like 
Discharge may found on vaginal walls , cervix and 
labia 
Commonly vulva is red ,&swollen labial folds , vagina 
and cervix may also be swollen 
Rarely a yeast or musty smell occurs
Screening and diagnosis 
Complete history acts as the valuable screening tool 
Physical examination – including complete 
examination of the vulva and vagina 
Speculum examination – always essential 
Saline and potassium hydrooxide (KOH) mounts – 
Prepared from vaginal or labial secretion, vaginal ph 
is normal in yeast infection 
Microscopic examination- Shows hypae and spores 
of candida albicans 
On saline mounts the vaginal epithelium cells appear 
normal , there are numerous lactobacilli ( normal 
flora and few white blood cells )
TREATMENT 
Vaginal tablets or creams such as mycostatin , 
miconazole , clotrimazole, terconazole and 
triconozole are prescribed for insertion once daily for 
7 to 14 days 
Shorter regimen : terazol and 
butaconazole( femstat) in a 3 day regimen... 
& 
mycelex G-500 AND vagistat ( 0.5%in 
a single treatment)
Persistent or chronic candida vaginitis treated with 
oral anti fungal medications , such as mycostatin , 
ketoconazole or fluconazole 
Single oral dose of fluconozole is as effective as 3days 
of intravaginal clotrimazole 
Prophylactic oral fluconozole once a month can 
control recurrent infections( can cause liver toxicity , 
hence liver test to be done)
Teaching points 
Minipad can be advised during the day to absorb the 
drainage 
Women should not use tampoons during treatment , 
as it absorbs the medication 
Douching to be avoided , and intercourse to 
preferably stopped or a condom used during the 
intercourse 
Vulvar inflammations and itching are severe – 
antifungal or steroidal creams can be applied for 
several days
If candida vagnitis is recurrent , male partner should 
be examined and skin scraping to be done
BACTERIAL INFECTIONS 
BACTERIAL VAGINOSIS ( VAGINAL INFECTIONS) 
Caused by gardnerella vaginalis or haemophilus 
vaginitis , a short gram negative rod ( cocco bacillus) 
often seen in combination with mobiluncus species , 
mycoplasma hominis and anaerobic bacteria , such 
as non- fragile bacteroides species 
Common in vaginal flora , but cause symptoms when 
crowded out the lactobacillus species
Etiology 
Exact etiology is unknown 
PATHOPHYSIOLOGY 
Normal h202 lactobacilli are replaced with high 
concentration of anaerobic bacteria ( gardnerella and 
mobilluncus) 
With more proliferation of anaerobic , the level of 
vaginal amines is increased and normal acidic ph of 
vagina is altered 
Epithelial cell slough and numerous bacteria attach to 
their surface 
Amines are volatilized , then the characteristic odour 
of BV occurs
Symptoms 
Fishy odour in the vaginal area 
B.V discharge is usually profuse , thin, vulvar and 
vaginal inflammation are commonly seen 
Serious consequences can arise if infection is severe 
–cellulitis , PID , intra-amniotic infections , post 
partum endometriosis , preterm labour , recurrent 
urinary tract infection
Screening and diagnosis 
Careful history – to help distinguish from other 
vaginal infections 
Microscopic examination of vaginal secretion 
Normal saline and 10% potassium hydroxide smear 
to be made 
Presence of clue cells by wet smear is highly 
diagnostic – is specific to BV 
Clue cells appearances is due to vaginal epithelial 
cells appear stippled due to growth of gardenerellla 
and other organisms
Management 
Oral metronidazole 5oomg orally twice a day for 7 
days 0r 2gms in a single dose 
Clindamycin 300 mg orally tid for 7day s is an 
alternative 
Clindamycin phosphate vaginal cream 2%at bed time 
for 7days or metronidazole vaginal gel at bedtime for 
5 days 
When administering metronidazole advice to be 
given for avoiding alcohol
Side effects of metronidazole – sharp , unpleasant 
metallic taste in mouth , furry tongue , central 
nervous system reaction, urinary tract disturbances 
Metronidazole contraindicated in pregnancy and 
lactating mother , coz high concentration seen in 
infants . If necessary to follow pump and dumb 
method
BV AND PREGNANCY COMPLICATIONS 
Includes 
Postpartal infections 
Preterm labour and delivery 
Preterm rupture of membrane 
Fever during labour 
Postpartal endometriosis 
Intra amniotic infections 
Post caesarean endometriosis
Case detection 
Clinical criteria and through vaginal examination 
B.V is diagnosed when atleast three of the follwoing 
criteria are present 
A. Vaginal ph is above 4.5 
B.Thin, homogenous , white or gray vaginal 
discharge 
C.Clue cells present on saline prep of vaginal 
discharge 
D.presence of fishy amine odour with additional of 
10%potassium hydroxide to vaginal fluid
GROUP B STREPTOCOCCUS 
VAGINAL INFECTIONS 
Group b streptococcus considered as a part of the 
normal vaginal flora in women and is present in 9 to 
23% of the healthy pregnant women 
Incidences 
Associated with poor pregnancy outcomes
RISK FACTORS 
Positive culture for Group b STREPTOCOCCUS 
Preterm of less than 37 weeks of gestation 
Premature rupture of membrane for a duration of 18 
hours or more 
Intrapartum maternal fever higher than 38 c
Diagnosis 
Prenatal screening done by vaginal or cervical 
cultures at 26 to 32 weeks gestation 
GBS culture is recommended for pregnant women 
admitted for premature or prolonged rupture of 
membrane , premature labour, fever during labour 
and multiple births 
EIA TEST for GBS antigen provides for rapid 
detection but sensitivity may be low , leading to false 
negative
GROUP B STREPTOCOCCAL DISEASES IN 
NEONATES 
Occurs in 2 to 4% of 1000 live births 
Rates of infections are 1 to 2 per 1000 births , and 
mortality rate of 30% 
Sepsis apparent birth or may not appear until after 1 
week 
Infection lead to puenmonia, bacteremia , meningitis 
with residual neurologic development deficits or 
deaths
Late onset of disease – occurs after 7days and may 
cause meningitis , bacteremia and bone and joint 
infection
TREATMENT 
PRENATAL 
Ampicillin 500mg orally QID for 7days given in the 
third trimester ( rdeuce colonization prior to 
delivery) 
Erythromycin used in case for penicillin sensitive 
client 
Sexual partners treated with ampicillin to prevent 
recolonization 
Use of condoms
INTRAPARTUM 
Ampicillin 2g iv intially followed by 1 t0 2 g iv q6h 
during labour 
Erthromycin or clindamycin is used with penicillin 
allergy 
NEOANATE WITH EVIDENCE OF INFECTION 
Parental ampicillin 75 mg /kg q12h plus gentamycin 
2.5 mg/ kg q12h starting within 2 hours after birth 
continuing for 10 days
EFFECTS OF GROUP B STREPTOCCCOUS 
INFECTIONS 
Pregnancy effects fetal 
effects 
Preterm labour preterm birth 
Premature rupture of membrane 
Chorioamniotis 
Postpartum sepsis 
Urinary tract infection
CHLAMYDIA TRACHOMATIS INFECTION 
EPIDEMIOLOGY 
Caused by chylamydia trachomatis 
High prevalence among adolescents and young 
adults 
More than 4 million cases annually 
Is a intracellular organism that infects the lower 
genital tract of women and men causing urethritis
RISK FACTORS 
age of 24 or younger 
multiple sexual partner 
New sexual partner 
friable cervix 
non barrier method of contraception or no 
contraception
SYMPTOMS 
Two third of the cases are asymptomatic 
Symptom consists a complex of pelvic pain , fever , 
tenderness and muco-purulent cervical discharge 
indicating PID OR salphingitis 
ANTEPARTUM 
Reviews of various studies show that ante partum 
trachomatis causes amniotis and postpartum 
endometroisis 
Chylamydia cerviticis occurs in 30% pregnant 
women
NEWBORN 
Newborn infections – upto 60 to 70% i.e during 
passage via the birth cannael 
Inclusion conjuntivitis of newborn – most common 
infection occuring in upto 50% of exposed newborns 
Chlamydia neonatal ophthalmia is also seen 
Infected neonate many also develop pneumonia
DIAGNOSIS 
Direct immunoflurescent monoclonal antibody stain 
and enzyme linked immunosorbent assay ( ELISA) 
and polymerase chain reaction – provide rapid and 
accurate diagnosis 
Elisa and PCR developed that can be used in urine 
and genital swab specimens
Treatment 
Acc to CDC recommendes – treating women and 
partner 
Treatment regimen includes : 
Doxy cycline hyclate 100 mg orally BD for 7days 
Azithromycin 1 gram orally single dose 
Erthromycin 500mr orally QID for 7days 
Ofloxacin 300mg orally bid for 7days 
Sulfisoxozole 500 mg orally qid for 10 days
TREAMENT DURING PREGNANCY...... 
Doxycycline, erythromycin, estolate and ofloxacin 
are contraindicated 
Erthromycin or sulfisoxazole may be used , but 
sulfisoxazole is less effective 
Amoxicillin or clindamycin is also effective 
treatment
Prevention 
Prevention of neonatal trachomatis infections: 
Newborns routinely treated prophylactically aganist 
ocular chylamdial infection 
Topical erythromycin or tetracycline ointments are 
used 
Chlymadial pneumonia and conjunctivits in 
neonates – treated with systemic erthromycin
GONORRHEA 
One the oldest communicable sexuaaly transmitted 
disease 
caused by gram negative Coccus Nesserei gonorrhea 
– commonly infects the mucosa of the lower genital 
tract 
Other sites of infections include endocervical glands , 
urethra, anus and oropharynx 
Also spread by oral to genital and anal to genital 
Evidence show infection spread from vagina to 
rectum 
Also transmitted to neonate in the form of opthalmia 
neonatorum
Risk factors 
Sexually active individuals 
Young adults 
African – amercian 
Multiple sexual partners
SYMPTOMS 
Women are asymptomatic : one third of infections 
seen in adolescents, symptoms are unnoticed 
Purulent endocervical dischanrge , dicharge minimal 
or absent 
 complaints of Pain Chronic or acute severe pelvic or 
lower abdominal pain or longer , painful menses 
Infrequent dysuria, vague abdominal pain or lower 
back pain 
Gonococcal rectal infection – Ocuur in women after 
anal intercourse with 10 % to 30 % urogential 
infections
Contd... 
Individual with rectal gonnorhea – may be 
completely asymptomatic or conversely have severe 
symptoms with profuse purulent anal discharge , 
rectal pain and blood in stool . 
Rectal itching , fullness , pressure are commen 
symptoms
Gonorrhoea infection in pregnancy... 
Gonococcal infection in pregnancy affects mother 
and fetus – so routine gonorrhea testing is 
recommended in early pregnancy and repeated at 28 
weeks 
Women with cervical gonorhinginits may develop in 
first trimester 
Perinatal infection with gonorhaea can lead to 
premature rupture of membranes , preterm births , 
chorioamniotics , sepsis , intrauterine growth 
restrictions and maternal postpartum sepsis
GONORHEA IN NEWBORNS CAUSES – 
 OPTHALMIC NEONATORIUM is the common 
manifestaion – highly contagious , if untreated can 
lead to blindness 
INFECTIONS OF the nasopharygeal passage , vagina 
, anus , earcannals and scalp abscesses
SCREENING ND DIAGNOSIS 
CDC recommends screening of all women 
All pregnant women routinely screened at the first 
prenatal visit and infected those identified with risky 
behaviours are rescreened 
For diagnosis cultures are obtained from – 
endocervix, the rectum and the pharynx 
Diagnosis is confirmed if it shows intracellular gram 
negative diplococci .i.e culture done on a gram stain
Management 
CDC recommendation for uncomplicated urethral , 
endocervical or rectal infections are dual therapy 
with one of the following 
 ceftriaxone sodium 125mg IM single dose 
Cefixime (suprax) 400mg oral single dose 
Ciprofloxacin HCL 500MG orally single dose 
Ofloxacin (fluxacin) 400mg orally single dose 
Spectinomycin hcl ( TROBIN) 2GM im single dose 
combined with doxycycline 100 mg orally bd for 
7days
Fluroquinolone – not to be used in pregnant and 
younger than 18 years 
Gonorrhoea with co-existing Chlamydi- 7days of 
doxycycline ( not used for prg women)or single dose 
of azithromycin is added
Gonorrhoea during pregnancy ... 
Treated with ceftrixone 125 mg IM or other 
cephalosporins ( spectinomycin 2 gm IM if allergic) 
plus erythromycin base 500 mg orally QID for 7days 
In neonates prophylatically against gonococcal 
opthalmia - topical application of 1% silver nitrate 
- also erythomycin , tetracycline ointment 
NEWBORNS INFECTED PERINATALLY – treatment 
with parental antibiotics
SYPHILLIS 
CAUSED by spirochete treponema pallidum 
one of the earliest described diseases STI’S 
Transmitted through exposure to infected exudate 
during sexual contact, by contact with open wound 
or infected blood or congenitally 
Rate of acquisition from that of a infected person is 
30% 
Disease also transmitted by kissing, biting, hugging.
INCIDENCES 
More than 30,000 new cases of primary and 
secondary occur anually 
Incidences increased during the 1985 to 1990 , 
presently still continue to increase in incidences
SYMPTOMS 
Infection manifest itself in stages with different 
symptoms 
Primary syphilis is characterized by primary lesion . 
Ie the CHANCRE , appears 5 to 90 days after 
infection 
Lesion begins as painless papule then erodes to form 
a non tender , shallow , indurated , clean ulcer with 
several millimeters to centimeters to size
Secondary syphiilis – occurs 6 weeks to 6 months 
after apperance of chancre 
Characterized widespread , symmetric 
maculopapular rash on the palms and soles with 
generalized lymphanopathy 
May also develop fever , headache and malaise 
Condylomata (broad, painless, pink grey wart like 
infection ) develop on vulva , the perineum or anus 
If untreated , some women enter latent phase others 
develop teritary syphilis – 1/3 rd of women
Contd...... 
Neurological , cardiovascular musculoskeletal or 
multiorgan complications can develop in third stage
Syphilis during pregnancy 
Can be transmitted to fetus through placental 
circulation as early as 6th week 
Clinical manifestation of disease in foetus usually do 
not occur unless infection is present in women after 
16 week of gestation 
Risk of prematurity , perinatal death and congential 
syphilis is greater during primary or secondary 
syhilis 
Congenital syphilis – is systemic 
infections,newborns affected heptosplenomegaly , 
hemolytic anemia , osteochondritis , bullous skin 
eruptions containing spirochetes
Screening and Diagnosis 
All women diagnosed with another STI’ S OR WITH 
HIV infections TO BE screened for syphillis 
All pregnant women to be screened for syphillis at 
first prenatal visit 
Two types of serologic tests are used : NON 
TREPONEMAL and TREPONOMAL
CONTD.. 
Non- treponemal tests- SUCH AS VDRL , rapid 
plasma reagin are used as screening tests 
False postive test results are seen for acute 
infections, autoimmune , malignancy . 
The TREPONEMAL tests – FLURORESCENT 
TREPONEMAL antibody absorbed and micro 
hemagglution assays for antibody to T.pallidium, are 
used to confirm POSTIVE TESTS 
Tests results for early or incubating syphillis may be 
negative
MANAGEMENT 
Penicillin is drug of choice 
Proven therapy used even during pregnancy 
Parental penicillin – drug of choice treatment for all 
stages of syphillis
DOSAGE 
Less than 1 year duration single dose of 2.4 million U 
benzathine penicillin G IM 
More than 1 year duration , three doses of 2.4 million 
U BENZATHINE penicillinG im WEEKLY for 3 
weeks 
Neuro syphilis 10 to 14 days of iv penicillin or 
procaine penicillin IM plus oral probenecid 
Penicillin allergy in non pregnant client 
-Erthromycin
CHANCROID 
Diseases caused by H.ducreyi
INCIDENCES 
Prevalent in India 
Incidence now found to have decline 
Different states present with different status, highest 
amoung them been recorded in the northeast with 
retropective data showing highest incidences of 
about 25.7% 
Diseases is less common in the developed and more 
prevalent in the developing countries 
Found in minority ethincity , multiple sexual 
partners, prostitution, and drug users
Diagnosis 
Made by presences of a powerful genital ulcer ,a 
negative test for syphilis and herpes and bilateral 
inguinal lymphdenopathy 
Ulcer – usually deeper , softer at edges and more 
irregular than syphilitic chancre 
More painfull and one or more lesions will be 
present
TREATMENT 
AZITHROMYCIN 1GM orally single dose 
OR 
CEFTRIAXONE 250 MG IM single dose 
OR 
CIPROFLOXACIN 500 MG orally , twice daily for 
3days 
OR 
ERTHROMYCIN BASE 500MG ORALLY , 3times 
daily for7day 
Erthromycin contraindicated during preg, 
Following treatment women to be reexamined
MOLLUSCUM CONTAGIOSUM 
Member of the pox virus 
Frequently seen in chlidren as skin infections 
Found commonly in the tropical areas , disturbution 
is world wide
Risk factors 
Among adults through sexual transmission – more 
common spread 
 poverty 
Inadequate resource for good hygiene 
Overcrowding 
Transmission occurs through contact with infected 
skin. 
Apart from sexual route also transmitted through 
from personal objects , that has been contact with 
lesions by skin to skin contact 
Infection also transmitted by touching infected areas 
and then touching other body parts
Signs and symptoms 
Cause a benign infection of skin 
Firm raised flesh coloured nodules with a softly 
indented centres from small papules 
Average size less than 0.5 cm 
Central area is filled a soft curd like materials , that 
can be expressed 
Nodule appear on the genitals , buttocks and thighs 
and chest 
Large lesion seen in immune suppressed pts
DIAGNOSIS 
Presumptive diagnosis made – ON CLINICAL 
PRESENTATION 
STAINING OF the material expressed form the 
nodules can identify typical molluscum bodies in the 
cytoplasm
TREATMENT 
A benign disease with limited course , it resolve 
spontaneously after week or month 
Cryotherapy , scraping the core material with a sharp 
object , curetting the lesion , applications of 
podophyllins in the office or podofilox at home
LYMPHANOGRANULOMA VENEREUM 
LGV is caused by some subgroup of cotrachomatis 
Genital ulcer may appear at site of initial infections , 
but resolves quickly 
More prominetly seen as tender lymphedenopathy , 
most commonly in the inguinal areas/femoral areas
Diagnosis 
By exclusion of other causes of lyphadenopathy or by 
compliment fixation testing
Treatment 
Doxy cycline – 100mg orally twice a day for 21days 
Erythromycin base 500mg – orally four times a day 
for 21 days 
All partners to be tested
VIRAL SEXUALLY 
TRANSMITTED DISEASES
HUMAN PAPILLOMA VIRUS 
Hpv also known as condylomata accuminata or 
genital warts 
Most common viral STI’S in ambulatory health 
setting 
HPV a double stranded DNA virus , which has more 
than 30 serotypes ,that can be sexually transmitted , 
five of which are known to cause genital warts 
formation , eight of which causes oncogenic potential 
About 70 tyoes of hpv virus , skin commonly infected 
by 1,2 ,3 ,4 and mucuosa by hpv 6, 11, 16, 18
Incidences 
Dramatic rise in hpv infections in last 20 years with 
estimated incidences at about 17% 
Younger women have higher rate of incidences 
Cervical hpv rates 33% and combined cervix and 
vuvla rates of 46%
Risk factors 
Younger age 
Multiple sexual partners 
Failure to use condom
Signs and symptoms 
Lesions large , cauliflower like clusters or condyloma 
,usally multiple , although single lesions can be seen 
on the vulva, vagina ,cervix and rectum 
Lesions are small 2 to 3 mm in diameter and 10 to 15 
mm in height 
Papillary swelling occuring singly or in clusters on 
the genital and anal rectal regions 
Infection of longer duration look like cauliflower like 
mass 
In moist areas such as vaginal introtus , lesions look 
like multiple fine finger projections
Complain of profuse , irritating vaginal discharge , 
itching , dyspareunia or post costal bleeding 
Women may report of bumps on her vulva 
Flat topped papules 1 to 4 mm in diameter are seen 
in cervis 
DURING PREGNANCY , the lesions become so large 
during pregnancy that the affect urination , 
defecation , mobility and fetal descent 
Hpv infection can also be acquired by neonate 
during birth
Screening and Diagnosis 
Complete h/o OF signs and symptoms , pap tests 
and physical examination 
Hpv – DNA test can be used in women over the age 
of 30 in combination with PAP test to screen for 
types of HPV or in women with abnormal PAP test 
Only definitive diagnosis is - for presences of 
histological evaluation of a biopsy specimen
MANAGEMENT 
Untreated warts may reslove on their own in young 
women , because of strong immune system 
No therapy eradicates HPV 
GOAL of treatment is removal of warts and relief of 
signs and symptoms , not eradication of HPV 
For pregnant women – cryotherapy with liquid 
nitrogen, TCA OR BCA 80 – 90% 
Women with discomfort associated with genital 
warts find bathing with oats meat solution and 
drying the area with cool bar drier.
Keep the area clean and dry. 
Cotton underwear and loose fitting clothes decrease 
friction and irritation and decrease discomfort. 
Women to be counseled regarding diet, rest and 
exercises. 
 also to be taught on virus transmission. 
Sexually active women with multiple partener or 
history of HPV to encourage to use latex condom.
To be instructed about medications and therapies 
available. 
Importance of concurrent treatment of vaginitis and 
other STD’S to be emphasized. 
Educate the importance of annual health 
examination to screen disease reoccurrence. 
Women should be counselled for regular pap 
screening.
prevention 
Prevention include abstinence from sexual activity. 
Staying in longterm monogamous relationship. 
Prophylactic vaccination(HPV) vaccine..
HERPES SIMPLEX VIRUS 
Incidence or history : 
Unknown until point of middle of 20th centuary, now 
a wide spread problem especially in the united states. 
Caused by two antigen subtypes, herpes simplex 
virus 1(HSV1) and herpes simplex virus 2(HSV2) 
HSV 2 is usually transmitted sexually and HSV1 non-sexually. 
HSV1 /commonly associated with gingivostomatitis 
and oral labio ulcers. 
HSV2 with genital lesions.
HS V 1 mainly seen as cold sores of lips. 
Risk factors: 
Lower income and educational levels. 
Multiple sexual partners 
African americans or hispanic race. 
Female gender
SYMPTOMS 
Multiple painful lesions , fever ,chills, malaise and 
severe dysuria and last upto 2 to 3 weeks 
Incubation period for primary infections is 3 to 14 
days 
Following this incubation period the women with 
HSV – 2 will develop painful vesicles in the vulva 
and perineal areas 
Women with primary genitla herpes progress 
forming vesciles , pustules and ulcers that crust and 
heal without scarring 
Ulcers become tender
Women also have itching , inguinal tenderness and 
lymphadenopathy 
Severe vulvar edema may develop and have diffculty 
sitting 
Cervix may appear normal or be friable , reddened , 
ulcerated or necrotic 
Heavy, watery to purulent vaginal discharge is also 
seen 
Extragental lesions may also be present 
Urinary retention and dysuria may occur secondary
Women with recurrent episodes of HSV infection 
commonly have only local symptoms , which are less 
severe
DURING PREGNANCY 
Have adverse effects both on mother and fetus 
Primary infection during the first trimester have 
been associated with increasing miscarriage rates 
More severe complications of HSV infections is 
neonatal herpes 
Risk for neonatal infections is heightened among 
women with primary herpes infection who are near 
term
Screening and Diagnosis 
A thorough history and physical examination 
History taking into account-any viral symptoms , 
malaise , headache, fever ,local symptoms like vulvar 
pain , dysuria, itching or burning at site of infection. 
A thorough physical examination – emphasis on 
vulva, perineal, vaginal and cervical area to be 
carefully inspected 
Confirmed by viral cultures or antibody titres using 
ELISA technique . 
Multinucleated giant cells on a pap smear also 
support diagnosis
MANAGEMENT 
Genital herpes – CHRONIC recurrent disease , for 
which there is no cure 
Mx aimed at specific treatment during primary and 
recurrent infections , preventions , self help measure 
and psychological support 
Systemic anti viral medication partially control 
symptoms and signs of HSV infection
IN NON PREGNANCT WOMEN 
Acyclovir 200mg orally five times daily or 
400 mg threee times daily for 10 days 
recurrent infections – acyclovir 200mg five times for 
daily for 5 days 
or 
800 mg twice daily for 5days started 
within 2 days after appearance of lesion 
CHRONIC SUPPRESSIVE THERAPY – with 400 mg 
acyclovir twice daily , helps reduce recurrences
IN PREGNANT WOMEN- Safety of acyclovir not 
established 
ACYCLOVIR can be used if benefits outweight the 
potential harm to the fetes 
Cleaning lesion twice a day with saline will help 
prevent secondary infection
Measures that increase comfort – warm sitz bath 
with baking soda 
keeping lesions dry by blowing the area , 
pat dry the area with soft towel 
Wearing cotton underwear and loose clothing 
Using drying aids such as hydrogen peroxide , 
burrows solutions or oatmeal baths , applying cool , 
wet , black tea bag to lesions and applying compress 
with infusion of cloves or pepper oil to lesions
Oral analgesics such as aspirin or ibubrofen is used 
to reduce pain sensation 
Non viral ointment , especially containing cortisol 
are extremely sensitive and such agents should be 
avoided 
A thin layer of lidocaine ointment or antiseptic spray 
may be applied to decrease discomfort 
Diet rich in vitamin c , B-complex vitamins , zinc and 
calicium – to help prevent recurrences
Contd.... 
Amino acid l-lysine has been used in doses of 750 – 
1000 mg daily while lesions are active and 500 mg 
during asymptomatic period 
Counselling and education 
Referral for stress reduction therapy , yoga , 
meditation 
Avoiding exercise , heat and sun , hot baths and 
using lubricant during sexual intercourse to reduce 
friction , to use condoms during intercourse
Vaginal births is preferred if there is not visible 
vaginal lesions 
 A Cesearen birth within 4 hours after labour begins 
or membranes rupture is recommened if visible 
lesions are present 
Infant delivered through infected vagina to be 
carefully observed and cultured
VIRAL HEPATITIS 
Five different viruses (hep A,hep B, C, D & E) 
HEPATITIS A 
Acquired primarily through feco- oral route by 
ingestion of contaminated foods, particularly milk, 
shell fish or polluted water or person to person 
contact 
Also transmitted through sexual contact
symptoms 
Abrupt onset of flu like symptoms 
Abdominal pain 
Fever 
Malaise , anorexia 
Nausea, vomiting 
Jaundice and puriritis 
incubation period of 15 to 20 days 
Transplacental transmission of HAV to fetus occurs 
rapidly
DIAGNOSIS 
 Detection of antiHAV antibodies in serum is 
elevated 
LFT –show elevated aspartate transaminase (AST) , 
Alanine aminotransferase (ALT), alkaline 
phosphates , cholestrol, and bilirubin
TREATMENT 
PREVENTION – vaccine ‘havrim” made from 
inactivated hepatitis virus , FDA approved this 
vaccine in 1995 
One dose is 96% effective 
Non immunized people who come in close contact 
with infected person to be given serum 
immunoglobulin within 14 days of exposure
HEPATITIS B 
Common cause of acute and chronic hepatitis 
Transmitted through sexual contact and blood fluids
Risk factors 
Women of asian, pacific islands or alaskan eskimo 
descent , women both in haitior , sub saharan africa 
Women with history of acute or chronic ulcer disease 
who work or receive treatment in dialysis unit 
Women with histroy of multiple blood transfusions 
Prison inmates 
Homesexuals 
Iv drug users 
Frequent blood users
Transmission 
Perinatal transmission occur in infants of mother 
who have acute infection in the third trimester or 
during postpartum or during intrapartum from 
exposure to positive vaginal secretion , blood 
amniotic fluid and breastmilk 
Also transmitted through artificial insemination
Symptoms 
Many are asymptomatic 
Classic symptoms – fatigue , nausea , anorexia , 
abdominal pain, low grade fever , and in 25% of 
cases jaundice 
Later women develop clay coloured stools, dark 
urine , increased abdominal pain and jaundice 
Infection become chronic , ranging from 
asymptomatic carriers to persistent hepatitis
Screening and diagnosis 
Thorough history and physical examination 
Serological testing for hepatitis B surface antigen 
(HBsAG)
HEP B IN pregnancy 
Newborns to receive prompt treatment and health 
care worker to take appropriate precaution 
HBV can be prevented in 85 – 95% OF NEWBORN 
by administering hepatitis B immunoglobulins , as 
soon as possible , within 12 to 48 hours after birth
TREATMENT 
HBV vaccine is administered in 3 doses , first two 
are given 1 month apart and third given in 6 months 
Pregnant women with definite exposure to HBV to 
be given hep b immunoglobins and to begin hep B 
vaccine series with 14 days of most recent contact 
Vaccine a series of three doses over 6 months 
period , with the first two doses given at least 1 
month apart , given in detoid muscle 
Prevention – to decrease transmission , women with 
positive HBV should maintain high level of 
personnel hygiene
HEPATITIS C VIRUS 
VIRUS rarely tranmitted through sexual route , 
mostly by blood or blood products , feco oral route 
RISK FACTORS 
h/o of injections , intravenous drugs 
h/o of STI such as hep b , Hiv 
Multiple sexual partners 
h/o of blood transfusion
Symptoms 
Clients are usally asymptomatic or have general flu 
like symptoms 
DIAGNOSIS 
Confirmation of HCV is confirmed by presences of 
anti- c antibody during laboratory testing 
TREATMENT 
Interferon alfa – 2b alone or with ribaviran for 6 to 
12 months is the main therpay for HCV 
INFECTIONS
HEPATITIS E VIRUS 
Usually causes an acute , self limiting icteric illness 
without chronic infections or liver diseases 
DELTA HEPATITIS 
OCCURS in inconjunction with HBV INFECTIONS 
Found in people with multiple parental exposures , 
such as iv drug users , hemophilias and those having 
repeated blood transfusions 
No treatment , should be encouraged plenty of sleep, 
eat nutritious food
HUMAN IMMUNODEFICIENCY VIRUS 
Spread throug HIV 1 AND HIV 2 . HIV 1 causes 
infections in europe and western hemisphere 
HIV 2 – is a retrovirus ENDEMIC in west africa
Transmission 
Primarily througH sexual contact , also through 
blood and body fluids , transplacentally and through 
breast milk
SYMPTOMS 
INCLUDE fever 
Headache 
Night sweats 
Malaise 
Generalized lymphadenopathy 
Myalgia 
Nausea 
Diarrhoea 
Weight loss 
Sore throat
Diagnosis 
FROM 6 weeks to 1 year after exposure , hiv 
antibodies appear in serum and detected by ELISA, 
which is usally confirmed by western blot test 
Antibody testing is done sensitive screening test 
such enzyme immunoassay (eia) 
Reactive screening test must be confirmed by 
additional tests such as western blot or an 
immunofluorescence test
INCIDENCE 
About one million people are estimated by CDC IN 
1991
HIV INFECTION IN PREGNANCY 
Druing prenatal visit , women to be screened for HIV 
RISK FACTORS 
Early indication of possible HIV infection include 
persistent candida infections , anogential condyloma 
and herpes simplex 
Hiv infection causes premature rupture of 
membranes , foetal death and low birth weight 
babies 
Higher incidences of infectious diseases during 
pregnancy – bacterial pneumonia ,
Perinatal transmission 
Factors affecting 
Preterm neonates are more like to be infected 
Identical twins more likely to be infected 
Vitamin A Deficiency 
Newborns of symptomatic mothers 
Mothers with lower CD4 – CD 8
NEWBORN born by C section are slightly less likely 
to be infected 
Invasive procedures such as episiotomy , internal 
foetal monitoring, foetal scalp sampling , use of 
forceps and vacuum extraction during labour
Management for perinatal transmission 
Zidovudiene administered to a symptomatic 
seropositive women during pregnancy and labour 
and to newborn 
According to the united states public health service , 
issued recommendation regarding use of 
ZIDOVUDIENE 
Asymptomatic women with CD4 lymphocyte count 
above 200 , not yet taken zidovudiene- decrease the 
risk for prenatal transmission 
Pregnant women with HIV who have lower cd4 
counts or more than 34 weeks gestation 

Treatment 
All pregnant women CD4 COUNT to be detremined 
IF > 600 cells/ul , repeat count not needed 
If 200 – 600 cells/ul repeat each trimester 
If < 200 celles/ul repeat every 3 months to monitor 
antiretroviral therapy 
When CD4 COUNT is less than 500 cell/ul pregnant 
women to be started with antiretroviral therapy
Pelvic inflammatory disease 
Infectious process that commonly involve the uterus 
( fallopian ) tubes , and rarely the ovaries and 
peritoneal surfaces 
Causes 
Multiple organism 
Common causitive organisms is n. Gonnorrhea and 
chlamydia
Risk factors 
Young age 
Multiple partners 
High risk of new partners 
History of sti’s 
Women who use IUD
SYMPTOMS 
Acute , subacute and chronic 
Pain is a common- dull , intermittent 
ACUTE PID 
I. intermentrual bleeding 
II.Fever of 39 c or above , uretheral or cervical 
discharge , often purulent 
III.Peritonitis 
IV.Pelvic tenderness, adnexal tenderness
WOMEN WITH SUBACUTE PID 
Far less dramatic .with lesser severity and extent of 
sypmtoms , that women ignores them 
Symptoms – chronic lower abdominal pain , 
dyspareunia , menstrual irregularities , urinary 
discomfort , low grade fever , low back pain 
Abdominal examination shows no rebound 
tenderness
Screening and diagnosis 
Carefull h/o and vital signs 
Complete physical examination 
CRITERIA FOR DIAGNOSIS 
Oral temp greater than 38.3 
Abnormal cervical or vaginal discharge 
Elevated erythrocyte sedimentation rate 
Laboratory documentation with cervical infections 
with n.gonorrhea or trachomatis
Management 
Prevention counselling 
Instructing women for safe sex guideline 
Partner notification when STI’S is diagnosed 
CDC’S recommendation for hospitilization 
SURGICAL emergencies such as appendicitis 
Women with tuboovarian abscess 
Women is pregnant 
Women unable to follow outpatient command 
Failed to respond to out pt treatment
Treatment regimen vary depending on the infecting 
organisms , a broad spectrum antibiotics are 
generally given
TORCH INFECTIONS 
TOXOPLASMOSIS, AND other infections ( eg . 
Heptatitis)rubella virus , cytomeglovirus (cmv) and 
herpes simplex virus , collectively called as TORCH 
infections
Toxoplasmosis 
A protozoal infection caused by toxoplasmagondi 
Infection transmitted through encysted organisms 
by eating infected raw or uncooked meat , through 
contact with infected cat feaces 
Fetal risk for infection with duration of pregnancy is 
15% , 30%,60%in the first trimester, 2 nd 3 rd 
trimester 
Increased risk for abortion, still births , and IUGR 
AFFECTED develop hydrocephalous , 
choroidentitis . Microcephaly and mental retardation
Is a self limited illness in an immuno-competent 
adult and does not require any treatment 
 DIAGNOSIS 
Acute infection is diagnosed by detecting IgM 
specific antibody
Current infection is confirmed then the following 
test are carried out 
1. aminocentesis and cordiocentesis for detection of I 
g M antibodies 
TREATMENT 
Pyrimethamine 25 mg orally daily or oral sulphiazine 
1 gm four times a day is effective 
Luecovorin is added to minimize toxicity , fro 4- 6 
weeks consecutively 
Pyrimethamine not given in first trimester – 
spiramycin has been used as alternatively
PREVENTION 
Avoid uncooked meat, unpasturized milk , contact 
with stray cat or
Rubella 
Or german measles TRANSMITTED BY respiratory 
droplet exposure 
Fetal affect is through transplacental route 
Risk for major anomalies when infection occurs int 
the first , second, and 3rd trimester are 50%, 25% and 
10% respectively
Signs 
Multi sytem abnormalities, following cogenital 
rubella 
Cochlear , cardiac , haematologic and chromosomal 
abnormalities 
Virus predominant affect the fetus especially during 
1 st trimester and ITS IS EXTREMELY 
TETRATROGENIC 
Increased chance for abortions , stillbirths and 
congential malformed baby
DIAGNOSIS 
Test for rubella psecific antibody to be done within 
10 days of exposure , to know whther pateint is still 
immuno or not
Treatment 
Active immunity can be conferred in non immune 
clients 
Clients given live attenuated rubella virus vaccine 
during 11 – 13 yrs 
NOT RECOMMENDED in pregnant women, when 
given during child bearing period , pregnancy to be 
prevented within 3 months by contraceptive 
measures
CONTROL OF STD’S 
1.INTIAL PLANNING 
Based on the prevalence of the area – to be obtained 
Prioritisation to be based on multiple infected areas 
Appropriate strategies to be layed down 
2. INTERVENTION STRATEGIES 
Cases under doubt- confirmed using screening and 
contact tracking technique 
In cluster testing – pt asked to name persons moving 
in the same socio – sexual environment,
Need is stressed on contact treatment to control the 
spread of STD’S 
Consists – administering full therapeutic dose of 
treatment to persons exposed to STD’S 
Pts adviced to follow the appropriate contraceptive 
during sexual activity 
Through functional STD’S clinic operable at the 
district level even at PRIMARY HEALTH CENTER 
Suitable arrangement for treating female patients
The clinic / health centre / hospital ,to have 
adequate laboratory facility to provide basis for 
correct aetiological diagnosis, treatment, and follow 
up care 
Taking complete history , including the behavioural 
risk management 
Early diagnosis of RTI/STD an integral part of chain 
of prevention of life threatening diseases 
Management and counselling for safe sex pratices
SAFE SEX PRATICE 
Reducing the numbers of partners and avoiding 
partners who have had previous sexual practices 
Discussing new partners previous sexual history and 
exposure to STI will help reduce the risks 
Women to be taught low risk sexual practice and 
which sexual practice to avoid 
Sexual fantasizes is safe , as are hugging , body 
rubbing and massage
Women to be taught in the clinic , where to 
purchase condoms, how to use them , motivating 
them to use condoms 
All clinics , gynaecological procedure to be carried 
out in aseptic way , otherwise lead to RTI 
SOCIAL WELFARE – to eradicate the existence of 
RTI/STI include rehabilitation of prostitution , 
provision of descent living condition , marriage , 
counselling , prohibiting the sale of sexual 
stimulating literature, pronographic books and 
photographs
3. MOINTORING AND EVALUATION 
Monitoring the disease trends and evaluation of the 
program 
Periodic evaluation direct method to judge 
effectively

Tropical diseases

  • 1.
    Tropical diseases :Psychiatric disorders,Infections : toxoplasmosis , rubella , RTI, STI, vaginal infections
  • 2.
  • 3.
    Meaning Any disturbanceof emtional equlibrium , as manifested in maladptive behaviour and impaired functioning caused by genetic , physical, chemical,biological, psychological or social or cultural factors . Also called as emotinal illness, mental illness , or mental disorders . Disorder can occur any where during the period of pregnancy Mosby medical dictionary
  • 4.
    Common psychiatric challengesin pregnant women 1. MATERNAL STRESS Animal research shows that stress produce both long term and short term effects on the foetus Human studies showed – 6 month dutch famine of 1944- 1945 , showed the pregnancy outcome for women who experienced severe food shortage  Data showed , affected pregnancy had shorter gestation and higher risks for still births , with impact more pronounced if exposed in the first trimester
  • 5.
    Babies exposed inthird tirmester had large drop in birth weights Chance for neonatal deaths if exposed in the first and third trimesters Other research studies show- increased riskfor preterm death
  • 6.
    2. Mood disorders DEFINTION Defined as the disorders that have as their dominant features a disturbance in the prevailing emotional state Incidences In review of 21 research studies , prevalence of depression during pregnancy as 7.4% during first trimester , 12.8%during second trimester , 12%during third trimester
  • 7.
    CRITERIA FOR DIAGNOSIS For diagnosis major depression should have the following signs and symptoms 1. depressed mood , often with spontaneous crying Markedly diminished interest in activities Insomnia or hypersomnia Weight changes ( increased or decreased ) Pschomotor retardation or agitation Fatigue Feeling of worthlessness or inappropriate guilt Suicidal ideation Dimished ability to concentrate APA 2000
  • 8.
    TREATMENT Avoid givingantidepressants during the first trimester Symptoms are severe ( mood lability , disorganization, inability to care for self , cognitive deficit ), then medication is considered Fluoxetine ( prozac in small doses) Other options include , tricyclic and tetracyclic antidepressants , but excessive doses known to maternal toxicity like urinary retention , irritability , with fetal complications
  • 9.
    3. ANXIETY DISORDERS Most common mental disorder Includes phobias ( irrational fears , that leads to avoid objects, persons or situation ) panic disorders , generalized anxiety disorders (constant worry , untreated to any event ), obsessive compulsive disorders and post traumatic stress disorder
  • 10.
    TYPES A. PANICDISORDER Definition Repeated unprovoked episodes of intense fear which develop without warning and are not related to any specific event Incidences In a estimated systemic review showed an 1-2% in pregnancy, with women having no change or improvement of symptoms
  • 11.
    Study of 38,000mothers in hungarian , reported 0.5% of mothers carried a diagnostic panic disorders and high rate of preterm labour
  • 12.
    3. Obsessive CompulsiveDisorders (OCD) Meaning Includes reccurrent , persistent and intrusive thoughts that cause anxiety , which a person tries to control by performing repetitive behaviours or compulsions (APA 2000) PREVALANCE 0.2- 1.2% ocds in pregnancy
  • 13.
    TREATMENT Includes antidepressantsmedications ( SSRI), Cognitive behavioural therapy and education on management of symptoms
  • 14.
    POST TRAUMATIC STRESSDISORDER PTSD can occur because of any trauma manily traumas eg : rape
  • 16.
    SYMPTOMS RExperiencing thetraumatic event Persistent avoidance of stimuli Numbing Difficulty sleeping Hyper vigilance Exaggerated startle response
  • 17.
    Pregnancy because ofrape- women becomes extremely ambivalent about baby Women might avoid examination like pv, if prenatal examination triggers memories of original trauma ( triggered by bodily touch) Pregnant women with PTSD have associated psychiatric problems such as substance abuse , panic disorders , eating disorders and depressions which play a vital role in determining fetal outcome
  • 18.
    D. GENERALIZED ANXIETYDISORDERS INCIDENCES 8.5% of pregnant women develop generalized anxiety disorder
  • 19.
    Level of anxieties MILD Experience and manage tension related to activities of daily living She sees, hears and is aware of environmental stimuli Anxiety acts as motivator , helping women establish tasks
  • 20.
    MODERATE Attention focuson immediately concerns , what she hears , sees and perceives is compromised SEVERE Clients perceptual field is restricted significantly, narrowing her awareness Intent to relieve or reduce anxiety to a more reasonable or comfortable level
  • 21.
    PANIC Experience awe,dread , and terror Unable to follow commands Increased motor activity Loses capacity to think and reason, can dangers self or others
  • 22.
    OTHER PSYCHIATRIC DISORDERS 4a. SCHIZOPHRENIA  a debilitating psychiatric disorders affecting 1% of population Etiology No theory explains accurately
  • 23.
    Clinical manifestations Fivesubtypes of schizophrenia 1. paranoid – per occupation with one or more delusion, frequent hallucination usually auditory, organized speech and behaviour with appropriate effects 2.DISORGANIZED – Disorganized speech, disorganized behaviour , flat and appropriate affect 3. CATATONIC- at least two of the following 1. motor immobility with waxy flexilibility, or stupor 2. puporseless but excessive motor activity not influenced but external stimuli and demand
  • 24.
    3.Negativism 4. Maintenance 5. Mutisms 4. UNDIFFERENTAITED – delusions , hallucination and disorganized speech , but no symptoms that meet the predetermined criteria for paranoid disorganized or catatonic 5. RESIDUAL – no prominent delusions, hallucinations , disorganized speech , or disorganized or catatonic behaviour, negative thoughts , contents , form usual perceptual experience
  • 25.
    MOOD CHANGES Signsand Symptoms Experience anxiety , depression, tension, irritation Isolates oneself from events and people Anhedonia COGNITIVE CHANGES Disordered thoughts Loses capacity to concentrate Conversation shifts from one topic to another irrerelvant Disturbance in thought content – mainly through delusion or false beliefs Delusions
  • 26.
    PERCEPTUAL CHANGES Hallucination Kinesthetic hallucination Illusions PHYSICAL CHANGES Early stages , clients present with sweaty palms, dilated pupils and mild tachycardia , psychomotor activity ( restlenesses)
  • 27.
    INTERPERSONAL DISTURBANCES Inappropriatebehaviours Bizzare behaviours Eg. Bangs her head , interrupt conversation, mutilate body part with knifes , attempted suicide, introduce inappropriate topic , laugh about that provoke saddness
  • 28.
    DISTURBANCES IN MOTORFUNCTIONS No interactions with others With catatonic , the client becomes rigid and unresponsive to crisis
  • 29.
    Management Primary assessment-interviewing and direct observation Interviewing focusing on signs and symptoms , degree of impaired thoughts processes , risks for injury or violence towards self or others , availability of support Early stage of treatment- focus on improving the clients sense of reality ( focus on real events during hallucination and delusions ), nurse not to engage in arguments , but rather gently introduce doubt , attempt to shift clients focus
  • 30.
    Nurse should tryto listen and try to clarify each meaning To watch for aggressive behaviours , risky behaviours like social isolation Nurse to model behaviour which help patient to built social skills and learn ways to built rapport with others Nurse to assess their knowledge , to provide teaching about illness, its symptoms management , necessity of following therpeutic regimen , signs of relapse and life style accomdation
  • 31.
    JOURNAL REVIEW ONPSYCHOTIC DISORDERS Psychotic disorders and its affect on fetal outcome with schizophrenia reported fewer total life time pregnancies , a low rate of live births and a high rate of losing the pregnancy  Pts with schizophrenia and schizoaffective disorder have higher number of chronic disease eg. HTN, DM Meta analysis – found a doubling of risk of stillbirth in pregnancy with psychotic disorder
  • 32.
    Schizophrenia associated withmore placental abnormalities and cardiac defects Another study shows- one third of women with active psychiatric symptoms have no contact with their psychiatric providers during pregnancy Pts with schizophrenia – said to have worse health behaviours like lack of exercise , smoking, poor diet and substance abuse
  • 33.
    Personality Disorders Definition Personality disorders are a group of mental disturba nces defined byDiagnostic andStatistical Manual of Mental Disorders (DSM-IV) as "enduring patterns] of inner experience and b ehavior" that are sufficiently rigid and deep-seated to bring a person into repeated conflicts with his or her social and occupational environment. Incidences SWEDISH STUDY- of 625 primiparous mother , found a prevalence of personality disorders to be 6.4%during pregnancy
  • 34.
    DSM-IV classifies personalitydisorders into three clusters based on symptom similarities: Cluster A (paranoid, schizoid, schizotypal): Patients appear odd or eccentric to others. Cluster B (antisocial, borderline, histrionic, narcissistic): Patients appear overly emotional, unstable, or self-dramatizing to others. Cluster C (avoidant, dependent, obsessive-compulsive): Patients appear tense and anxiety-ridden to others.
  • 35.
    DSM-IV classifies personalitydisorders into three clusters based on symptom similarities: Cluster A (paranoid, schizoid, schizotypal): Patients appear odd or eccentric to others. Cluster B (antisocial, borderline, histrionic, narcissistic): Patients appear overly emotional, unstable, or self-dramatizing to others. Cluster C (avoidant, dependent, obsessive-compulsive): Patients appear tense and anxiety-ridden to others.
  • 36.
    4b. EATING DISORDER INCIDENCE Study with nearly 15,000 women in the uk assessed women in their first trimester for active eating disorder – found 1.4% women with anorexia nervosa , 1.6% with bulima and 0.7% with both and a total prevalence of 3.7%
  • 37.
    Etiology Several theories Bielieve it arise , because of complex interactions among biological , environmental and socio- cultural factors . Family functioning, lifestyle and stress
  • 38.
    1. ANOREXIA NERVOSA Characterized by disturbed body image , extreme fear about being fat and emaciations. CLINICAL FEATURES Primary indicator- refusal to eat , weight below 85% normal for their age and height Women view their extreme thin bodies as fat Dieting , defective obsession with cooking for others and extreme exercises
  • 39.
    Women with anorexia– tend to be compliant , obedient , perfectionists , achieving in school, sports , employment Physiological consequences of self starvation can be life threating to mother and cause PTD of fetus Can lead to hypotension, bradycardia , hypothermia , chronic constipation and electrolyte imbalance
  • 40.
    2. BULLIMA NERVOSA Characterized by consumption of extreme amount of food (bingeging) with subsequent behaviours to eliminate the excess calories (purging) Women consume incredible calories in short period (2000 to 3000) per episode called as bingeing To prevent weight gain , induce vomiting , use laxatives , exercise obsessively Women will be high achievers Physiological complications include changes HR, RHYTHM, GASTRIC DILATION , ELECTROLYTE IMBALANCE
  • 41.
    JOURNAL REVEIWING Womenwith active bulimia compared with women with prior diagnosis of bulimia ( with no active symptoms) showed twice rates of miscarriage , three times like hood of PTD AND nearly 6 times the odds gestational diabetes Higher rate of hyper emesis gravidarum seen in active bulima group Women with anorexia , also have significant higher risks of gestational diabetes and low birth weight ifants
  • 42.
    COLLABORARIVE MANAGEMENT treatment is hard because clients deny their problems Combination of therapy , cognitive behavioural therapy , family therapy  medication generally not primary treatment measure , but can also be treated with anti depressants , anti anxiety drugs . Lithium and anti convulsants Through physical examination, , weight , h/o of previous high and low weight , chronology of recent weight flucations
  • 43.
    h/o of desirablefood and fluid intake , any problems related to elimination , questions on type of food , exercise , difficulty sleeping and energy levels Laboratory and cardiac testing , electrolyte imbalances Main intervention focus on nutritional balance Fetal health concerns to be addressed Encourage realistic thinking process Improving clients self esteem, bodyimage and develop effective coping and problem solving strategies Extreme cases hospitalization is required
  • 44.
    INTIMATE PARTNER VIOLENCE Women who experinece IPV are at risk for developing depression, anxiety , eating didorder , alcoholisms, post traumatic stress disorder and numerous other maladise ( coker , 2005)
  • 45.
    Substance abuse inpregnancy Defintion Refers to the continued use of substance despite related problems in physical , social or interpersonal areas ( APA/ 2000) MAJOR depression and anxiety disorders are the psychiatric disorders that commonly occur with substance abuse
  • 46.
    Risk factors Womenbegin using during period of depression to relax , feel more comfortable, to lose weight, to decrease stress , or to help slepp at nightn Peer pressure in teens Lower educational attainment Lower rates of employement Psychological factors like : low self esteem, tendency to seek pleasure , and to avoid pain h./o family dysfuntion , psychiatric illness , or physical or sexual abuse
  • 47.
    BARRIERS TO TREATMENT Less than 10% take treatment Social stigma, labelling and gulit are social barriers Dont seek help, due to fear of losing custody
  • 48.
    CONCERNS RELATED TOPREGNANCY Use of substance lead to premature labour, abruptio placenta , still birth and numerous other complications Alcohol related , lead to fetal alcohol syndrome ,symptoms being microcephaly , mental retardation, attention deficit , hyperactivity disorder Use of cocaine –( fetus) IUGR , organ malformation, preterm labour, abruptio placenta , withdrawal symptoms to neonate for months
  • 49.
    Heroine – withdrawalsymptoms for mother and infants or both , irritability , poor feeding , respiratory complication , and neurological difficulties
  • 50.
    COLLABORATIVE MANAGEMENT Clientdeny their addictions or blame people or circumstance Client taught on coping with stressors, repair realtionship Abstinences , counselling and peer support
  • 51.
    PSYCHOPHARMACOLOGIC THERAPY DURINGPREGNANCY Use of psychiatric drugs pose a threat to manage psychiatric problems – due to detrimental effects on fetus or newborn development Assumed that all psychotropic drugs cross the blood placental barrier
  • 52.
    1. DETREMINING RISKAND BENFITS Health care providers to assess the risks and benefits of maternal drug therapy Concerns include – possibility of Lbw babies , sucidality, inability to engage in appropriate obstetric care Basic rule to avoid administering any medication Consent made jointly by partner , the women and health care worker Aims – at maintaining the lowest level of therapeutic dose
  • 53.
    US FOOD ANDDRUG ADMINISTRATION Not approved psychotropic agents for treatment of mental illness during pregnancy or lactation Developed classification system for prescribing drugs CATEGORY 1. A - controlled studies shows no risk . Well controlled studies have failed to demonstrate risk to fetus 2.B- no evidence of risk in humans : EITHER animal findings show risk , but humans donot or adequate human studies have been done
  • 54.
    C- risk cannotbe ruled out. Human studies are lacking and animal studies are either positive for fetal risks or lacking as well . Potential benfits amy justify potential risks D- postive evidence of risk . Investigation shows risk to fetus . Potential benefits may outweigh risks X- contraindicated in pregnancy . Studied in animal and humans shows fetal risks , that clearly outweigh any possible benefits to the patient
  • 55.
    System and currentresearch – developed creation of three categories of somatic risks to fetus and nweborns with use of psychotropic agents 1. teratogenicity and organ malformation 2. Neonatal toxicity 3. neurobehavioural and developmental teratogenic effects
  • 56.
    Medication for psychiatricdisorders A. ANTIDEPRESSANTS A. Tricyclic anti depressants ( TCA’S ) API committee on drugs ( 2001) has suggested , clinician proceed with caution with use of such drugs as support has not been established Nullman and colleages ( 1997)- Reported that in utero exposure to fluoxetine or TCA’S didnot affect either neurodevelopemental or behaviour in preschool childrens. Other studies showed higher rates of perinatal complications
  • 57.
    TCA’S cause centralnervous system and peripheral nervous system side effects , overdose cause death Side effects for mother – inlcude weight gain, tremors , grand mal seizures , night mares , agitation or mania and extra pyradimal side effects , anti cholinergic effects
  • 58.
    MONOAMINE OXIDASE INHIBITORS( MAOI’S ) Fall in the category” C” of FDA’S MAOI’S not to be used during pregnancy USEof MAOI’S require dietary restriction associated with preventing hypertensive crisis Dangerous food include –beer, red wine, aged cheese , smoked fish , brewers yeast , beef and chicken livers , yoghurts, bananas, soy sauce , chocolates
  • 59.
    SELECTIVE SEROTININ REUPTAKEINHIBITORS Emerging as first line agent in treatment Relatively safe and carry fewer side effects than TCA’S Not to be taken with DEXTROMETHORPHAN (cough syrup ) combination trigger serotonin syndrome Frequent side effects in mother – gastro intestinal disturbances , headache and insomnia 1/3 rd clients show reduced libido , arousal o orgasmic functions
  • 60.
    MOOD STABILIZERS Usedto treat mental illness- mainly bipolar disorder Lithium carbonate is major mood stabilizers , but its use is contraindicated in pregnancy Alternative to lithium in pregnancy are anticonvulsants ex. Carbmazepine , valproic acid , donazepam
  • 61.
    ANXIOLYTICS Benzodiazepines aremost frequently preferred This class drugs can aclumate in the fetus if given to the mother for a longer period of time These drugs should be withdrawal abruptly amd must be tapered significantly before birth to prevent infant withdrawal Benzodiazepines produce infant withdrawal syndrome that last longer than 3 months
  • 62.
    ANTIPSYCHOTICS Used tomanage schizophrenia and other though disorders in women Msot fall in the “c” category of FDA category , indicating they are associated with rare anomalies , such as fetal jaundice and anticholingenric effect at birth Said that all psychotics drugs cross the placental barrier, predisposing infants to numerous problems
  • 63.
     studies haveshown so far that 3 antipsychotic i.e haloperidol, perphenazine , and chloropromazine , have shown no direct link to congenital malformation Other drugs cause in women- extrapyramidal side effects , neuroleptic malignant syndrome
  • 64.
    Nursing management Nurseto see that , the clients have adequate knowledge about their health status A. DISCUSSING INFORMED CONSENT Nursing responsibility to make client is whole knowledge about the risk of psychotropic mediation during pregnancy . Through discussion on risk verus benefits need to be done
  • 65.
    B.DOCUMENTING RISK VERSUSBENFITS Document potential risk for any illness if untreated ,including risks to the women and fetus and infants Critical decison based on scientific knowledge , the clients clinical history , cultural consideration and personal preferences
  • 66.
    C. Promoting communityand psychosocial interventions To Maintain these women in the community Community focused interventions- case management, rehabilitation , self help groups and day hospitalization
  • 67.
    D. TEACHING STRESSMANAGEMENT Being pregnant , can produce stress Body reaction to stress is flight and fight techniques Common physical reaction to stress – increased bp, palpation, tense muscle , poor or excessive appetite and disturbed sleep Common symptoms – short tempered , feeling tired frequently, eating toomuch or too little , sleeping too much or too little , changes in menstrual cycle , forgetfullness, frustration, irritability , diffculty to concentrate and sleep distubances
  • 68.
    Diseases can alsooccur- heart diseases, DM, irritable bowel syndrome , depression ,UTI, asthma Management- behavioural change Specific strategies – prioritizing responsibilities , taking time to relax , exercising , become involved in social support systems , healthy perspectives , powerful strategies to improve quality of life Regular sleep routines
  • 69.
    E.ASSISTING WITH ACESSTO HEALTH CARE F.PROMOTING HEALTH LITERACY
  • 70.
    INFECTIONS : TOXOPLASMOSIS,RUBELLA , RTI’S , STD’S ,VAGINAL INFECTIONS
  • 71.
    DEFINTIONS SEXUALLY TRANSMITTEDDISEASES A group of communicable diseases that are transmitted predominantly by sexual contact and caused by a wide range of bacterial , viral , protozoal , fungal and ectoparasitites REPRODUCTIVE TRACT INFECTIONS Infections that occur in the reproductive tract and it encompasses both sexually transmitted and other common genital tract infections
  • 72.
    PREVALANCE True incidenceof STD’S unknown – because of inadequate reporting and secrecy that surround them 1. gonorrhea – 6.2 million 2. genital chylamyidial infections – 89 million 3. syphyillis – 12 million 4. chancroid – 2 million
  • 73.
    Viral STD’S genitalherpes – 20 million human papilloma virus infection- 30 million trichomoniasis – 170 million ( who health situvation 1994)
  • 74.
    Prevalance of diseasein india SYPHILLIS – a prevalence of 2.4 GONORRHEA – most cases are unreported 80% INFECTED women are asymptomatic carriers CHLAMYDIA – mostly prevalent in the southern states DONOVANOSIS- Greater prevalence in the coastal region , endemic in T.N, A.P, ORISSA
  • 75.
    Epidemi0logy A. HOSTFACTORS AGE – 20- 24 years old,followed by 25- 29 yrs and 15- 19 yrs SEX- morbidity is higher for men then for women, but morbidity caused by infection is generally much more severe in women MARITAL STATUS – the frequency of STD’S is higher among single , divorced and separated womens than among married couples SOCIO ECONOMIC STATUS – individual from low socio economic have higher morbidity
  • 76.
    B. SOCIAL FACTORS PROSTITUTION- prostitutes act as reservoir of infections major incidences in asia is accounted to prostitution BROKEN HOMES – promiscuous women are drawn from broken homes eg. Homes that are broken due to death of parents , or their separations , reared in unhappy homes SEXUAL DISHARMONY – married people with strained relations, divorced and separated persons are often victims of STD’S
  • 77.
    EASY MONEY –prostitution provides way for occupation and for earning easy money , fostered with lack of female employement EMOTIONAL IMMATURITY URBANIZATION AND INDUSTRIALIZATION- type of life styles contribute to infections SOCIAL DISRUPTION- caused by disasters , wars , civil unrest INTERNATIONAL TRAVEL – travellers can import and export infections
  • 78.
    CHANGING BEHAVIOURS PATTERNS– Moral and cultural value , tendency to break from traditional ways of life to newer ways of living SOCIAL STIGMA – Leads to non detecting of cases , not disclosing the case nor the source and hence it leads to infection ALCOHOLISM- effect boast prostitution
  • 79.
    CLASSIFICATION OF SEXUALLY TRANSMITTED DISEASES A. BACTERIAL INFECTIONS 1. gonnorrhea- Neisseria Gonorrhea 2 chlamydia 3. syphilis -Treponema pallidium 4. chancroid -Hemophilus ducreyi 5. Lymphogranuloma venerum- Donavanis granulomatis 6. genital mycoplasmas- Mycoplasma vaginalis 7. group B streptococcus
  • 80.
    B.VIRAL INFECTIONS AIDS- HIV GENITAL HERPES – Herpes simplex virus (HSV) CONDYLOMA ACCUMINATA- HPV MOLLUSCUM CONTAGIOSUM- HPV -16,18,31 VIRAL HEPATITIS – Pox virus C. PROTOZOAL TRICHOMONAS VAGINITIS- trichomonas vaginalis
  • 81.
    d. Fungal Moniliavaginitis - candida albicans e. Parasites Scabies – sarcoptes scabies Pediculosis pubis
  • 82.
    Effects of sexuallytransmitted diseases 1. EFFECT IN THE REPRODUCTIVE TRACT Females- Infections , development of ectopic pregnancy, infertilty , pelvi inflammatory diseases, , chronic pelvic pain Males- inflammation of the epididymus , infertility, urethral stricutre Infants- eye infection, blindness
  • 83.
    2.ULCERATION OF UROGENTIAL TRACT, mouth, rectum , cardiovascular complications , peripheral nervous inflammatory disease , 3. TRICHOMONIASIS- parasitic infection causing vaginitis , arthritis, adverse effect of pregnancy – low birth weight babies , premature rupture of membrane
  • 84.
    4. Inflammation ofthe lymph node , ulcerative genitalia and elephantiasis – effects of chancroid and lymphogranulona 5. Genital herpes –Papular lesions and ulceration Carcinomas- hepatocellular carcinomas , caused by hepatitis B, kaposis sarcoma , bcell lymphomas
  • 85.
    Types of infections A. Protozoal infection TRICHOMONAS VAGINALIS(VAGINAL INFECTION) A unicellular protozoan flagellate Transmitted through sexual intercourse Women usually infects vagina and skene’s duct in men Can be present in the lower
  • 86.
    SYMPT OMS Vaginaldischarge – yellow green , frothy or bubbly and copious with a strong foul odour Cervix and upper vagina often tiny petechiae , due to inflammation With severe inflammation-vaginal wall, cervix and vulva may be oedematous and erythematous Moderate to severe itching Women- dysuria and dyspareunia secondary to inflammation
  • 87.
    Contd symptoms Symptomsvary form mild to severe MILD SYMPTOMS can be- discharge that is thin, slight , whitish yellow , without typical foul odour Often cervix and vagina demonstrate “ strawberry spot”
  • 88.
    DIAGNOSIS DURING PELVICEXAMINATION- Discharge samples placed on a saline mount and examined microscopically Motile trichomonades are seen Under high power seen as 2 to 3 times the size of WBC and their flagella may be seen moving Lactobacilli are usually absent, many WBC are present, array of vaginal intermediate and parabasal epithelial cells are present Routine pap smear indicates presence of trichomonades
  • 89.
    TREATMENT Treated withmetronidazole (flagyl) 2 gm orally in a single dose or 250mg tid for 5 to 7 days( contraindicate during the first trimester of pregnancy ) Womens sexual partner also to be treated with 2 gm single dose When taking to avoid alcohol , because it produces abdominal cramps , nausea, vomiting , headache and flushing
  • 90.
    Lactating women tobe treated with 2 grams metronidazole , but not to breast feed for 24 hours after the therapy Metronidazole is contraindicated during pregnancy , especially during the first trimester . Clotrimazole vaginal cream or tablets at bedtime for 7days can provide symptomatic relief
  • 91.
    Local vulvar inflammationand dysuria - to be treated with Sitz bath or steriod creams  For Dyspareunia – avoided for 2 to 3 days to allow for healing
  • 92.
    Fungal infections CANDIDAVAGINITIS ( vaginal infection)/ VULVO VAGINAL or yeast infection Caused by fungus Candida albicans widely distributed in nature , found in skin and mucous membrane Causes : occurs frequently in women with DM , Women taking systematic antibiotics are more susceptible to candidas due to suppression of normal vaginal flora and changes in PH and enzymes Stress – decreases resistances to candida vaginitis and hygiene practices such as douching , using perfumed oils
  • 93.
    SYMPTOMS Common symptomis – vulvar and possible vaginal pruritis Itching may be mild or intense , interfere with rest and activities , occur during or after intercourse Women c/o of period of dryness Others- have painful urination , usually results because of excoriation , resulting from scratching
  • 94.
    Discharge is thick,white , lampy and cottage cheese like Discharge may found on vaginal walls , cervix and labia Commonly vulva is red ,&swollen labial folds , vagina and cervix may also be swollen Rarely a yeast or musty smell occurs
  • 95.
    Screening and diagnosis Complete history acts as the valuable screening tool Physical examination – including complete examination of the vulva and vagina Speculum examination – always essential Saline and potassium hydrooxide (KOH) mounts – Prepared from vaginal or labial secretion, vaginal ph is normal in yeast infection Microscopic examination- Shows hypae and spores of candida albicans On saline mounts the vaginal epithelium cells appear normal , there are numerous lactobacilli ( normal flora and few white blood cells )
  • 96.
    TREATMENT Vaginal tabletsor creams such as mycostatin , miconazole , clotrimazole, terconazole and triconozole are prescribed for insertion once daily for 7 to 14 days Shorter regimen : terazol and butaconazole( femstat) in a 3 day regimen... & mycelex G-500 AND vagistat ( 0.5%in a single treatment)
  • 97.
    Persistent or chroniccandida vaginitis treated with oral anti fungal medications , such as mycostatin , ketoconazole or fluconazole Single oral dose of fluconozole is as effective as 3days of intravaginal clotrimazole Prophylactic oral fluconozole once a month can control recurrent infections( can cause liver toxicity , hence liver test to be done)
  • 98.
    Teaching points Minipadcan be advised during the day to absorb the drainage Women should not use tampoons during treatment , as it absorbs the medication Douching to be avoided , and intercourse to preferably stopped or a condom used during the intercourse Vulvar inflammations and itching are severe – antifungal or steroidal creams can be applied for several days
  • 99.
    If candida vagnitisis recurrent , male partner should be examined and skin scraping to be done
  • 100.
    BACTERIAL INFECTIONS BACTERIALVAGINOSIS ( VAGINAL INFECTIONS) Caused by gardnerella vaginalis or haemophilus vaginitis , a short gram negative rod ( cocco bacillus) often seen in combination with mobiluncus species , mycoplasma hominis and anaerobic bacteria , such as non- fragile bacteroides species Common in vaginal flora , but cause symptoms when crowded out the lactobacillus species
  • 101.
    Etiology Exact etiologyis unknown PATHOPHYSIOLOGY Normal h202 lactobacilli are replaced with high concentration of anaerobic bacteria ( gardnerella and mobilluncus) With more proliferation of anaerobic , the level of vaginal amines is increased and normal acidic ph of vagina is altered Epithelial cell slough and numerous bacteria attach to their surface Amines are volatilized , then the characteristic odour of BV occurs
  • 102.
    Symptoms Fishy odourin the vaginal area B.V discharge is usually profuse , thin, vulvar and vaginal inflammation are commonly seen Serious consequences can arise if infection is severe –cellulitis , PID , intra-amniotic infections , post partum endometriosis , preterm labour , recurrent urinary tract infection
  • 103.
    Screening and diagnosis Careful history – to help distinguish from other vaginal infections Microscopic examination of vaginal secretion Normal saline and 10% potassium hydroxide smear to be made Presence of clue cells by wet smear is highly diagnostic – is specific to BV Clue cells appearances is due to vaginal epithelial cells appear stippled due to growth of gardenerellla and other organisms
  • 105.
    Management Oral metronidazole5oomg orally twice a day for 7 days 0r 2gms in a single dose Clindamycin 300 mg orally tid for 7day s is an alternative Clindamycin phosphate vaginal cream 2%at bed time for 7days or metronidazole vaginal gel at bedtime for 5 days When administering metronidazole advice to be given for avoiding alcohol
  • 106.
    Side effects ofmetronidazole – sharp , unpleasant metallic taste in mouth , furry tongue , central nervous system reaction, urinary tract disturbances Metronidazole contraindicated in pregnancy and lactating mother , coz high concentration seen in infants . If necessary to follow pump and dumb method
  • 107.
    BV AND PREGNANCYCOMPLICATIONS Includes Postpartal infections Preterm labour and delivery Preterm rupture of membrane Fever during labour Postpartal endometriosis Intra amniotic infections Post caesarean endometriosis
  • 108.
    Case detection Clinicalcriteria and through vaginal examination B.V is diagnosed when atleast three of the follwoing criteria are present A. Vaginal ph is above 4.5 B.Thin, homogenous , white or gray vaginal discharge C.Clue cells present on saline prep of vaginal discharge D.presence of fishy amine odour with additional of 10%potassium hydroxide to vaginal fluid
  • 109.
    GROUP B STREPTOCOCCUS VAGINAL INFECTIONS Group b streptococcus considered as a part of the normal vaginal flora in women and is present in 9 to 23% of the healthy pregnant women Incidences Associated with poor pregnancy outcomes
  • 110.
    RISK FACTORS Positiveculture for Group b STREPTOCOCCUS Preterm of less than 37 weeks of gestation Premature rupture of membrane for a duration of 18 hours or more Intrapartum maternal fever higher than 38 c
  • 111.
    Diagnosis Prenatal screeningdone by vaginal or cervical cultures at 26 to 32 weeks gestation GBS culture is recommended for pregnant women admitted for premature or prolonged rupture of membrane , premature labour, fever during labour and multiple births EIA TEST for GBS antigen provides for rapid detection but sensitivity may be low , leading to false negative
  • 112.
    GROUP B STREPTOCOCCALDISEASES IN NEONATES Occurs in 2 to 4% of 1000 live births Rates of infections are 1 to 2 per 1000 births , and mortality rate of 30% Sepsis apparent birth or may not appear until after 1 week Infection lead to puenmonia, bacteremia , meningitis with residual neurologic development deficits or deaths
  • 113.
    Late onset ofdisease – occurs after 7days and may cause meningitis , bacteremia and bone and joint infection
  • 114.
    TREATMENT PRENATAL Ampicillin500mg orally QID for 7days given in the third trimester ( rdeuce colonization prior to delivery) Erythromycin used in case for penicillin sensitive client Sexual partners treated with ampicillin to prevent recolonization Use of condoms
  • 115.
    INTRAPARTUM Ampicillin 2giv intially followed by 1 t0 2 g iv q6h during labour Erthromycin or clindamycin is used with penicillin allergy NEOANATE WITH EVIDENCE OF INFECTION Parental ampicillin 75 mg /kg q12h plus gentamycin 2.5 mg/ kg q12h starting within 2 hours after birth continuing for 10 days
  • 116.
    EFFECTS OF GROUPB STREPTOCCCOUS INFECTIONS Pregnancy effects fetal effects Preterm labour preterm birth Premature rupture of membrane Chorioamniotis Postpartum sepsis Urinary tract infection
  • 117.
    CHLAMYDIA TRACHOMATIS INFECTION EPIDEMIOLOGY Caused by chylamydia trachomatis High prevalence among adolescents and young adults More than 4 million cases annually Is a intracellular organism that infects the lower genital tract of women and men causing urethritis
  • 118.
    RISK FACTORS ageof 24 or younger multiple sexual partner New sexual partner friable cervix non barrier method of contraception or no contraception
  • 119.
    SYMPTOMS Two thirdof the cases are asymptomatic Symptom consists a complex of pelvic pain , fever , tenderness and muco-purulent cervical discharge indicating PID OR salphingitis ANTEPARTUM Reviews of various studies show that ante partum trachomatis causes amniotis and postpartum endometroisis Chylamydia cerviticis occurs in 30% pregnant women
  • 120.
    NEWBORN Newborn infections– upto 60 to 70% i.e during passage via the birth cannael Inclusion conjuntivitis of newborn – most common infection occuring in upto 50% of exposed newborns Chlamydia neonatal ophthalmia is also seen Infected neonate many also develop pneumonia
  • 121.
    DIAGNOSIS Direct immunoflurescentmonoclonal antibody stain and enzyme linked immunosorbent assay ( ELISA) and polymerase chain reaction – provide rapid and accurate diagnosis Elisa and PCR developed that can be used in urine and genital swab specimens
  • 122.
    Treatment Acc toCDC recommendes – treating women and partner Treatment regimen includes : Doxy cycline hyclate 100 mg orally BD for 7days Azithromycin 1 gram orally single dose Erthromycin 500mr orally QID for 7days Ofloxacin 300mg orally bid for 7days Sulfisoxozole 500 mg orally qid for 10 days
  • 123.
    TREAMENT DURING PREGNANCY...... Doxycycline, erythromycin, estolate and ofloxacin are contraindicated Erthromycin or sulfisoxazole may be used , but sulfisoxazole is less effective Amoxicillin or clindamycin is also effective treatment
  • 124.
    Prevention Prevention ofneonatal trachomatis infections: Newborns routinely treated prophylactically aganist ocular chylamdial infection Topical erythromycin or tetracycline ointments are used Chlymadial pneumonia and conjunctivits in neonates – treated with systemic erthromycin
  • 125.
    GONORRHEA One theoldest communicable sexuaaly transmitted disease caused by gram negative Coccus Nesserei gonorrhea – commonly infects the mucosa of the lower genital tract Other sites of infections include endocervical glands , urethra, anus and oropharynx Also spread by oral to genital and anal to genital Evidence show infection spread from vagina to rectum Also transmitted to neonate in the form of opthalmia neonatorum
  • 126.
    Risk factors Sexuallyactive individuals Young adults African – amercian Multiple sexual partners
  • 127.
    SYMPTOMS Women areasymptomatic : one third of infections seen in adolescents, symptoms are unnoticed Purulent endocervical dischanrge , dicharge minimal or absent  complaints of Pain Chronic or acute severe pelvic or lower abdominal pain or longer , painful menses Infrequent dysuria, vague abdominal pain or lower back pain Gonococcal rectal infection – Ocuur in women after anal intercourse with 10 % to 30 % urogential infections
  • 128.
    Contd... Individual withrectal gonnorhea – may be completely asymptomatic or conversely have severe symptoms with profuse purulent anal discharge , rectal pain and blood in stool . Rectal itching , fullness , pressure are commen symptoms
  • 129.
    Gonorrhoea infection inpregnancy... Gonococcal infection in pregnancy affects mother and fetus – so routine gonorrhea testing is recommended in early pregnancy and repeated at 28 weeks Women with cervical gonorhinginits may develop in first trimester Perinatal infection with gonorhaea can lead to premature rupture of membranes , preterm births , chorioamniotics , sepsis , intrauterine growth restrictions and maternal postpartum sepsis
  • 130.
    GONORHEA IN NEWBORNSCAUSES –  OPTHALMIC NEONATORIUM is the common manifestaion – highly contagious , if untreated can lead to blindness INFECTIONS OF the nasopharygeal passage , vagina , anus , earcannals and scalp abscesses
  • 131.
    SCREENING ND DIAGNOSIS CDC recommends screening of all women All pregnant women routinely screened at the first prenatal visit and infected those identified with risky behaviours are rescreened For diagnosis cultures are obtained from – endocervix, the rectum and the pharynx Diagnosis is confirmed if it shows intracellular gram negative diplococci .i.e culture done on a gram stain
  • 132.
    Management CDC recommendationfor uncomplicated urethral , endocervical or rectal infections are dual therapy with one of the following  ceftriaxone sodium 125mg IM single dose Cefixime (suprax) 400mg oral single dose Ciprofloxacin HCL 500MG orally single dose Ofloxacin (fluxacin) 400mg orally single dose Spectinomycin hcl ( TROBIN) 2GM im single dose combined with doxycycline 100 mg orally bd for 7days
  • 133.
    Fluroquinolone – notto be used in pregnant and younger than 18 years Gonorrhoea with co-existing Chlamydi- 7days of doxycycline ( not used for prg women)or single dose of azithromycin is added
  • 134.
    Gonorrhoea during pregnancy... Treated with ceftrixone 125 mg IM or other cephalosporins ( spectinomycin 2 gm IM if allergic) plus erythromycin base 500 mg orally QID for 7days In neonates prophylatically against gonococcal opthalmia - topical application of 1% silver nitrate - also erythomycin , tetracycline ointment NEWBORNS INFECTED PERINATALLY – treatment with parental antibiotics
  • 135.
    SYPHILLIS CAUSED byspirochete treponema pallidum one of the earliest described diseases STI’S Transmitted through exposure to infected exudate during sexual contact, by contact with open wound or infected blood or congenitally Rate of acquisition from that of a infected person is 30% Disease also transmitted by kissing, biting, hugging.
  • 136.
    INCIDENCES More than30,000 new cases of primary and secondary occur anually Incidences increased during the 1985 to 1990 , presently still continue to increase in incidences
  • 137.
    SYMPTOMS Infection manifestitself in stages with different symptoms Primary syphilis is characterized by primary lesion . Ie the CHANCRE , appears 5 to 90 days after infection Lesion begins as painless papule then erodes to form a non tender , shallow , indurated , clean ulcer with several millimeters to centimeters to size
  • 138.
    Secondary syphiilis –occurs 6 weeks to 6 months after apperance of chancre Characterized widespread , symmetric maculopapular rash on the palms and soles with generalized lymphanopathy May also develop fever , headache and malaise Condylomata (broad, painless, pink grey wart like infection ) develop on vulva , the perineum or anus If untreated , some women enter latent phase others develop teritary syphilis – 1/3 rd of women
  • 139.
    Contd...... Neurological ,cardiovascular musculoskeletal or multiorgan complications can develop in third stage
  • 140.
    Syphilis during pregnancy Can be transmitted to fetus through placental circulation as early as 6th week Clinical manifestation of disease in foetus usually do not occur unless infection is present in women after 16 week of gestation Risk of prematurity , perinatal death and congential syphilis is greater during primary or secondary syhilis Congenital syphilis – is systemic infections,newborns affected heptosplenomegaly , hemolytic anemia , osteochondritis , bullous skin eruptions containing spirochetes
  • 141.
    Screening and Diagnosis All women diagnosed with another STI’ S OR WITH HIV infections TO BE screened for syphillis All pregnant women to be screened for syphillis at first prenatal visit Two types of serologic tests are used : NON TREPONEMAL and TREPONOMAL
  • 142.
    CONTD.. Non- treponemaltests- SUCH AS VDRL , rapid plasma reagin are used as screening tests False postive test results are seen for acute infections, autoimmune , malignancy . The TREPONEMAL tests – FLURORESCENT TREPONEMAL antibody absorbed and micro hemagglution assays for antibody to T.pallidium, are used to confirm POSTIVE TESTS Tests results for early or incubating syphillis may be negative
  • 143.
    MANAGEMENT Penicillin isdrug of choice Proven therapy used even during pregnancy Parental penicillin – drug of choice treatment for all stages of syphillis
  • 144.
    DOSAGE Less than1 year duration single dose of 2.4 million U benzathine penicillin G IM More than 1 year duration , three doses of 2.4 million U BENZATHINE penicillinG im WEEKLY for 3 weeks Neuro syphilis 10 to 14 days of iv penicillin or procaine penicillin IM plus oral probenecid Penicillin allergy in non pregnant client -Erthromycin
  • 145.
  • 146.
    INCIDENCES Prevalent inIndia Incidence now found to have decline Different states present with different status, highest amoung them been recorded in the northeast with retropective data showing highest incidences of about 25.7% Diseases is less common in the developed and more prevalent in the developing countries Found in minority ethincity , multiple sexual partners, prostitution, and drug users
  • 147.
    Diagnosis Made bypresences of a powerful genital ulcer ,a negative test for syphilis and herpes and bilateral inguinal lymphdenopathy Ulcer – usually deeper , softer at edges and more irregular than syphilitic chancre More painfull and one or more lesions will be present
  • 148.
    TREATMENT AZITHROMYCIN 1GMorally single dose OR CEFTRIAXONE 250 MG IM single dose OR CIPROFLOXACIN 500 MG orally , twice daily for 3days OR ERTHROMYCIN BASE 500MG ORALLY , 3times daily for7day Erthromycin contraindicated during preg, Following treatment women to be reexamined
  • 149.
    MOLLUSCUM CONTAGIOSUM Memberof the pox virus Frequently seen in chlidren as skin infections Found commonly in the tropical areas , disturbution is world wide
  • 150.
    Risk factors Amongadults through sexual transmission – more common spread  poverty Inadequate resource for good hygiene Overcrowding Transmission occurs through contact with infected skin. Apart from sexual route also transmitted through from personal objects , that has been contact with lesions by skin to skin contact Infection also transmitted by touching infected areas and then touching other body parts
  • 151.
    Signs and symptoms Cause a benign infection of skin Firm raised flesh coloured nodules with a softly indented centres from small papules Average size less than 0.5 cm Central area is filled a soft curd like materials , that can be expressed Nodule appear on the genitals , buttocks and thighs and chest Large lesion seen in immune suppressed pts
  • 152.
    DIAGNOSIS Presumptive diagnosismade – ON CLINICAL PRESENTATION STAINING OF the material expressed form the nodules can identify typical molluscum bodies in the cytoplasm
  • 153.
    TREATMENT A benigndisease with limited course , it resolve spontaneously after week or month Cryotherapy , scraping the core material with a sharp object , curetting the lesion , applications of podophyllins in the office or podofilox at home
  • 154.
    LYMPHANOGRANULOMA VENEREUM LGVis caused by some subgroup of cotrachomatis Genital ulcer may appear at site of initial infections , but resolves quickly More prominetly seen as tender lymphedenopathy , most commonly in the inguinal areas/femoral areas
  • 155.
    Diagnosis By exclusionof other causes of lyphadenopathy or by compliment fixation testing
  • 156.
    Treatment Doxy cycline– 100mg orally twice a day for 21days Erythromycin base 500mg – orally four times a day for 21 days All partners to be tested
  • 157.
  • 158.
    HUMAN PAPILLOMA VIRUS Hpv also known as condylomata accuminata or genital warts Most common viral STI’S in ambulatory health setting HPV a double stranded DNA virus , which has more than 30 serotypes ,that can be sexually transmitted , five of which are known to cause genital warts formation , eight of which causes oncogenic potential About 70 tyoes of hpv virus , skin commonly infected by 1,2 ,3 ,4 and mucuosa by hpv 6, 11, 16, 18
  • 159.
    Incidences Dramatic risein hpv infections in last 20 years with estimated incidences at about 17% Younger women have higher rate of incidences Cervical hpv rates 33% and combined cervix and vuvla rates of 46%
  • 160.
    Risk factors Youngerage Multiple sexual partners Failure to use condom
  • 161.
    Signs and symptoms Lesions large , cauliflower like clusters or condyloma ,usally multiple , although single lesions can be seen on the vulva, vagina ,cervix and rectum Lesions are small 2 to 3 mm in diameter and 10 to 15 mm in height Papillary swelling occuring singly or in clusters on the genital and anal rectal regions Infection of longer duration look like cauliflower like mass In moist areas such as vaginal introtus , lesions look like multiple fine finger projections
  • 163.
    Complain of profuse, irritating vaginal discharge , itching , dyspareunia or post costal bleeding Women may report of bumps on her vulva Flat topped papules 1 to 4 mm in diameter are seen in cervis DURING PREGNANCY , the lesions become so large during pregnancy that the affect urination , defecation , mobility and fetal descent Hpv infection can also be acquired by neonate during birth
  • 164.
    Screening and Diagnosis Complete h/o OF signs and symptoms , pap tests and physical examination Hpv – DNA test can be used in women over the age of 30 in combination with PAP test to screen for types of HPV or in women with abnormal PAP test Only definitive diagnosis is - for presences of histological evaluation of a biopsy specimen
  • 165.
    MANAGEMENT Untreated wartsmay reslove on their own in young women , because of strong immune system No therapy eradicates HPV GOAL of treatment is removal of warts and relief of signs and symptoms , not eradication of HPV For pregnant women – cryotherapy with liquid nitrogen, TCA OR BCA 80 – 90% Women with discomfort associated with genital warts find bathing with oats meat solution and drying the area with cool bar drier.
  • 166.
    Keep the areaclean and dry. Cotton underwear and loose fitting clothes decrease friction and irritation and decrease discomfort. Women to be counseled regarding diet, rest and exercises.  also to be taught on virus transmission. Sexually active women with multiple partener or history of HPV to encourage to use latex condom.
  • 167.
    To be instructedabout medications and therapies available. Importance of concurrent treatment of vaginitis and other STD’S to be emphasized. Educate the importance of annual health examination to screen disease reoccurrence. Women should be counselled for regular pap screening.
  • 168.
    prevention Prevention includeabstinence from sexual activity. Staying in longterm monogamous relationship. Prophylactic vaccination(HPV) vaccine..
  • 169.
    HERPES SIMPLEX VIRUS Incidence or history : Unknown until point of middle of 20th centuary, now a wide spread problem especially in the united states. Caused by two antigen subtypes, herpes simplex virus 1(HSV1) and herpes simplex virus 2(HSV2) HSV 2 is usually transmitted sexually and HSV1 non-sexually. HSV1 /commonly associated with gingivostomatitis and oral labio ulcers. HSV2 with genital lesions.
  • 170.
    HS V 1mainly seen as cold sores of lips. Risk factors: Lower income and educational levels. Multiple sexual partners African americans or hispanic race. Female gender
  • 171.
    SYMPTOMS Multiple painfullesions , fever ,chills, malaise and severe dysuria and last upto 2 to 3 weeks Incubation period for primary infections is 3 to 14 days Following this incubation period the women with HSV – 2 will develop painful vesicles in the vulva and perineal areas Women with primary genitla herpes progress forming vesciles , pustules and ulcers that crust and heal without scarring Ulcers become tender
  • 172.
    Women also haveitching , inguinal tenderness and lymphadenopathy Severe vulvar edema may develop and have diffculty sitting Cervix may appear normal or be friable , reddened , ulcerated or necrotic Heavy, watery to purulent vaginal discharge is also seen Extragental lesions may also be present Urinary retention and dysuria may occur secondary
  • 173.
    Women with recurrentepisodes of HSV infection commonly have only local symptoms , which are less severe
  • 174.
    DURING PREGNANCY Haveadverse effects both on mother and fetus Primary infection during the first trimester have been associated with increasing miscarriage rates More severe complications of HSV infections is neonatal herpes Risk for neonatal infections is heightened among women with primary herpes infection who are near term
  • 175.
    Screening and Diagnosis A thorough history and physical examination History taking into account-any viral symptoms , malaise , headache, fever ,local symptoms like vulvar pain , dysuria, itching or burning at site of infection. A thorough physical examination – emphasis on vulva, perineal, vaginal and cervical area to be carefully inspected Confirmed by viral cultures or antibody titres using ELISA technique . Multinucleated giant cells on a pap smear also support diagnosis
  • 176.
    MANAGEMENT Genital herpes– CHRONIC recurrent disease , for which there is no cure Mx aimed at specific treatment during primary and recurrent infections , preventions , self help measure and psychological support Systemic anti viral medication partially control symptoms and signs of HSV infection
  • 177.
    IN NON PREGNANCTWOMEN Acyclovir 200mg orally five times daily or 400 mg threee times daily for 10 days recurrent infections – acyclovir 200mg five times for daily for 5 days or 800 mg twice daily for 5days started within 2 days after appearance of lesion CHRONIC SUPPRESSIVE THERAPY – with 400 mg acyclovir twice daily , helps reduce recurrences
  • 178.
    IN PREGNANT WOMEN-Safety of acyclovir not established ACYCLOVIR can be used if benefits outweight the potential harm to the fetes Cleaning lesion twice a day with saline will help prevent secondary infection
  • 179.
    Measures that increasecomfort – warm sitz bath with baking soda keeping lesions dry by blowing the area , pat dry the area with soft towel Wearing cotton underwear and loose clothing Using drying aids such as hydrogen peroxide , burrows solutions or oatmeal baths , applying cool , wet , black tea bag to lesions and applying compress with infusion of cloves or pepper oil to lesions
  • 180.
    Oral analgesics suchas aspirin or ibubrofen is used to reduce pain sensation Non viral ointment , especially containing cortisol are extremely sensitive and such agents should be avoided A thin layer of lidocaine ointment or antiseptic spray may be applied to decrease discomfort Diet rich in vitamin c , B-complex vitamins , zinc and calicium – to help prevent recurrences
  • 181.
    Contd.... Amino acidl-lysine has been used in doses of 750 – 1000 mg daily while lesions are active and 500 mg during asymptomatic period Counselling and education Referral for stress reduction therapy , yoga , meditation Avoiding exercise , heat and sun , hot baths and using lubricant during sexual intercourse to reduce friction , to use condoms during intercourse
  • 182.
    Vaginal births ispreferred if there is not visible vaginal lesions  A Cesearen birth within 4 hours after labour begins or membranes rupture is recommened if visible lesions are present Infant delivered through infected vagina to be carefully observed and cultured
  • 183.
    VIRAL HEPATITIS Fivedifferent viruses (hep A,hep B, C, D & E) HEPATITIS A Acquired primarily through feco- oral route by ingestion of contaminated foods, particularly milk, shell fish or polluted water or person to person contact Also transmitted through sexual contact
  • 184.
    symptoms Abrupt onsetof flu like symptoms Abdominal pain Fever Malaise , anorexia Nausea, vomiting Jaundice and puriritis incubation period of 15 to 20 days Transplacental transmission of HAV to fetus occurs rapidly
  • 185.
    DIAGNOSIS  Detectionof antiHAV antibodies in serum is elevated LFT –show elevated aspartate transaminase (AST) , Alanine aminotransferase (ALT), alkaline phosphates , cholestrol, and bilirubin
  • 186.
    TREATMENT PREVENTION –vaccine ‘havrim” made from inactivated hepatitis virus , FDA approved this vaccine in 1995 One dose is 96% effective Non immunized people who come in close contact with infected person to be given serum immunoglobulin within 14 days of exposure
  • 187.
    HEPATITIS B Commoncause of acute and chronic hepatitis Transmitted through sexual contact and blood fluids
  • 188.
    Risk factors Womenof asian, pacific islands or alaskan eskimo descent , women both in haitior , sub saharan africa Women with history of acute or chronic ulcer disease who work or receive treatment in dialysis unit Women with histroy of multiple blood transfusions Prison inmates Homesexuals Iv drug users Frequent blood users
  • 189.
    Transmission Perinatal transmissionoccur in infants of mother who have acute infection in the third trimester or during postpartum or during intrapartum from exposure to positive vaginal secretion , blood amniotic fluid and breastmilk Also transmitted through artificial insemination
  • 190.
    Symptoms Many areasymptomatic Classic symptoms – fatigue , nausea , anorexia , abdominal pain, low grade fever , and in 25% of cases jaundice Later women develop clay coloured stools, dark urine , increased abdominal pain and jaundice Infection become chronic , ranging from asymptomatic carriers to persistent hepatitis
  • 191.
    Screening and diagnosis Thorough history and physical examination Serological testing for hepatitis B surface antigen (HBsAG)
  • 192.
    HEP B INpregnancy Newborns to receive prompt treatment and health care worker to take appropriate precaution HBV can be prevented in 85 – 95% OF NEWBORN by administering hepatitis B immunoglobulins , as soon as possible , within 12 to 48 hours after birth
  • 193.
    TREATMENT HBV vaccineis administered in 3 doses , first two are given 1 month apart and third given in 6 months Pregnant women with definite exposure to HBV to be given hep b immunoglobins and to begin hep B vaccine series with 14 days of most recent contact Vaccine a series of three doses over 6 months period , with the first two doses given at least 1 month apart , given in detoid muscle Prevention – to decrease transmission , women with positive HBV should maintain high level of personnel hygiene
  • 194.
    HEPATITIS C VIRUS VIRUS rarely tranmitted through sexual route , mostly by blood or blood products , feco oral route RISK FACTORS h/o of injections , intravenous drugs h/o of STI such as hep b , Hiv Multiple sexual partners h/o of blood transfusion
  • 195.
    Symptoms Clients areusally asymptomatic or have general flu like symptoms DIAGNOSIS Confirmation of HCV is confirmed by presences of anti- c antibody during laboratory testing TREATMENT Interferon alfa – 2b alone or with ribaviran for 6 to 12 months is the main therpay for HCV INFECTIONS
  • 196.
    HEPATITIS E VIRUS Usually causes an acute , self limiting icteric illness without chronic infections or liver diseases DELTA HEPATITIS OCCURS in inconjunction with HBV INFECTIONS Found in people with multiple parental exposures , such as iv drug users , hemophilias and those having repeated blood transfusions No treatment , should be encouraged plenty of sleep, eat nutritious food
  • 197.
    HUMAN IMMUNODEFICIENCY VIRUS Spread throug HIV 1 AND HIV 2 . HIV 1 causes infections in europe and western hemisphere HIV 2 – is a retrovirus ENDEMIC in west africa
  • 198.
    Transmission Primarily througHsexual contact , also through blood and body fluids , transplacentally and through breast milk
  • 199.
    SYMPTOMS INCLUDE fever Headache Night sweats Malaise Generalized lymphadenopathy Myalgia Nausea Diarrhoea Weight loss Sore throat
  • 200.
    Diagnosis FROM 6weeks to 1 year after exposure , hiv antibodies appear in serum and detected by ELISA, which is usally confirmed by western blot test Antibody testing is done sensitive screening test such enzyme immunoassay (eia) Reactive screening test must be confirmed by additional tests such as western blot or an immunofluorescence test
  • 201.
    INCIDENCE About onemillion people are estimated by CDC IN 1991
  • 202.
    HIV INFECTION INPREGNANCY Druing prenatal visit , women to be screened for HIV RISK FACTORS Early indication of possible HIV infection include persistent candida infections , anogential condyloma and herpes simplex Hiv infection causes premature rupture of membranes , foetal death and low birth weight babies Higher incidences of infectious diseases during pregnancy – bacterial pneumonia ,
  • 203.
    Perinatal transmission Factorsaffecting Preterm neonates are more like to be infected Identical twins more likely to be infected Vitamin A Deficiency Newborns of symptomatic mothers Mothers with lower CD4 – CD 8
  • 204.
    NEWBORN born byC section are slightly less likely to be infected Invasive procedures such as episiotomy , internal foetal monitoring, foetal scalp sampling , use of forceps and vacuum extraction during labour
  • 205.
    Management for perinataltransmission Zidovudiene administered to a symptomatic seropositive women during pregnancy and labour and to newborn According to the united states public health service , issued recommendation regarding use of ZIDOVUDIENE Asymptomatic women with CD4 lymphocyte count above 200 , not yet taken zidovudiene- decrease the risk for prenatal transmission Pregnant women with HIV who have lower cd4 counts or more than 34 weeks gestation 
  • 206.
    Treatment All pregnantwomen CD4 COUNT to be detremined IF > 600 cells/ul , repeat count not needed If 200 – 600 cells/ul repeat each trimester If < 200 celles/ul repeat every 3 months to monitor antiretroviral therapy When CD4 COUNT is less than 500 cell/ul pregnant women to be started with antiretroviral therapy
  • 207.
    Pelvic inflammatory disease Infectious process that commonly involve the uterus ( fallopian ) tubes , and rarely the ovaries and peritoneal surfaces Causes Multiple organism Common causitive organisms is n. Gonnorrhea and chlamydia
  • 208.
    Risk factors Youngage Multiple partners High risk of new partners History of sti’s Women who use IUD
  • 209.
    SYMPTOMS Acute ,subacute and chronic Pain is a common- dull , intermittent ACUTE PID I. intermentrual bleeding II.Fever of 39 c or above , uretheral or cervical discharge , often purulent III.Peritonitis IV.Pelvic tenderness, adnexal tenderness
  • 210.
    WOMEN WITH SUBACUTEPID Far less dramatic .with lesser severity and extent of sypmtoms , that women ignores them Symptoms – chronic lower abdominal pain , dyspareunia , menstrual irregularities , urinary discomfort , low grade fever , low back pain Abdominal examination shows no rebound tenderness
  • 211.
    Screening and diagnosis Carefull h/o and vital signs Complete physical examination CRITERIA FOR DIAGNOSIS Oral temp greater than 38.3 Abnormal cervical or vaginal discharge Elevated erythrocyte sedimentation rate Laboratory documentation with cervical infections with n.gonorrhea or trachomatis
  • 212.
    Management Prevention counselling Instructing women for safe sex guideline Partner notification when STI’S is diagnosed CDC’S recommendation for hospitilization SURGICAL emergencies such as appendicitis Women with tuboovarian abscess Women is pregnant Women unable to follow outpatient command Failed to respond to out pt treatment
  • 213.
    Treatment regimen varydepending on the infecting organisms , a broad spectrum antibiotics are generally given
  • 214.
    TORCH INFECTIONS TOXOPLASMOSIS,AND other infections ( eg . Heptatitis)rubella virus , cytomeglovirus (cmv) and herpes simplex virus , collectively called as TORCH infections
  • 215.
    Toxoplasmosis A protozoalinfection caused by toxoplasmagondi Infection transmitted through encysted organisms by eating infected raw or uncooked meat , through contact with infected cat feaces Fetal risk for infection with duration of pregnancy is 15% , 30%,60%in the first trimester, 2 nd 3 rd trimester Increased risk for abortion, still births , and IUGR AFFECTED develop hydrocephalous , choroidentitis . Microcephaly and mental retardation
  • 216.
    Is a selflimited illness in an immuno-competent adult and does not require any treatment  DIAGNOSIS Acute infection is diagnosed by detecting IgM specific antibody
  • 217.
    Current infection isconfirmed then the following test are carried out 1. aminocentesis and cordiocentesis for detection of I g M antibodies TREATMENT Pyrimethamine 25 mg orally daily or oral sulphiazine 1 gm four times a day is effective Luecovorin is added to minimize toxicity , fro 4- 6 weeks consecutively Pyrimethamine not given in first trimester – spiramycin has been used as alternatively
  • 218.
    PREVENTION Avoid uncookedmeat, unpasturized milk , contact with stray cat or
  • 219.
    Rubella Or germanmeasles TRANSMITTED BY respiratory droplet exposure Fetal affect is through transplacental route Risk for major anomalies when infection occurs int the first , second, and 3rd trimester are 50%, 25% and 10% respectively
  • 220.
    Signs Multi sytemabnormalities, following cogenital rubella Cochlear , cardiac , haematologic and chromosomal abnormalities Virus predominant affect the fetus especially during 1 st trimester and ITS IS EXTREMELY TETRATROGENIC Increased chance for abortions , stillbirths and congential malformed baby
  • 221.
    DIAGNOSIS Test forrubella psecific antibody to be done within 10 days of exposure , to know whther pateint is still immuno or not
  • 222.
    Treatment Active immunitycan be conferred in non immune clients Clients given live attenuated rubella virus vaccine during 11 – 13 yrs NOT RECOMMENDED in pregnant women, when given during child bearing period , pregnancy to be prevented within 3 months by contraceptive measures
  • 223.
    CONTROL OF STD’S 1.INTIAL PLANNING Based on the prevalence of the area – to be obtained Prioritisation to be based on multiple infected areas Appropriate strategies to be layed down 2. INTERVENTION STRATEGIES Cases under doubt- confirmed using screening and contact tracking technique In cluster testing – pt asked to name persons moving in the same socio – sexual environment,
  • 224.
    Need is stressedon contact treatment to control the spread of STD’S Consists – administering full therapeutic dose of treatment to persons exposed to STD’S Pts adviced to follow the appropriate contraceptive during sexual activity Through functional STD’S clinic operable at the district level even at PRIMARY HEALTH CENTER Suitable arrangement for treating female patients
  • 225.
    The clinic /health centre / hospital ,to have adequate laboratory facility to provide basis for correct aetiological diagnosis, treatment, and follow up care Taking complete history , including the behavioural risk management Early diagnosis of RTI/STD an integral part of chain of prevention of life threatening diseases Management and counselling for safe sex pratices
  • 226.
    SAFE SEX PRATICE Reducing the numbers of partners and avoiding partners who have had previous sexual practices Discussing new partners previous sexual history and exposure to STI will help reduce the risks Women to be taught low risk sexual practice and which sexual practice to avoid Sexual fantasizes is safe , as are hugging , body rubbing and massage
  • 227.
    Women to betaught in the clinic , where to purchase condoms, how to use them , motivating them to use condoms All clinics , gynaecological procedure to be carried out in aseptic way , otherwise lead to RTI SOCIAL WELFARE – to eradicate the existence of RTI/STI include rehabilitation of prostitution , provision of descent living condition , marriage , counselling , prohibiting the sale of sexual stimulating literature, pronographic books and photographs
  • 228.
    3. MOINTORING ANDEVALUATION Monitoring the disease trends and evaluation of the program Periodic evaluation direct method to judge effectively